"ParameterPath","Value","Formula","RHSFormula"
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SA proportionality factor,9500,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Specific clearance (endosome),0.2052,K_uptake-K_rec>=0 ? K_uptake-K_rec : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Surface area scaling exponent,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Volume (plasma),2.94986852810143,V_pls_art+V_pls_bon+V_pls_brn+V_pls_cae+V_pls_colasc+V_pls_coldesc+V_pls_colsigm+V_pls_coltrans+V_pls_duo+V_pls_fat+V_pls_tes+V_pls_hrt+V_pls_kid+V_pls_lin+V_pls_lil+V_pls_lje+V_pls_lng+V_pls_mus+V_pls_pan+V_pls_prc+V_pls_prp+V_pls_pve+V_pls_rect+V_pls_skn+V_pls_sin+V_pls_spl+V_pls_sto+V_pls_uil+V_pls_uje+V_pls_ven,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Weight,73.0000004444493,Weight_blood + Weight_tissue,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Weight of blood organs,2.42053716877759,P_1 + P_2 + P_3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Weight of tissue organs,70.5794632756717,P_1 + P_2 + P_3 + P_4 + P_5 + P_6 + P_7 + P_8 + P_9 + P_10 + P_11 + P_12 + P_13 + P_14 + P_15 + P_16,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Estimated gestational age,1605.35714285714,Age* 365.25/7 + GA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|BMI,0.235666323748868,Height>0 ? BW / (Height)^2 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|BSA,188.918809746449,1.6667 * W^0.5 * (H*10)^ 0.5,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|pH (blood cells),7.22,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|pH (interstitial),7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|pH (intracellular),7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|pH (plasma),7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Scaling exponent for fluid recirculation flow rate,0.667,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Thickness (endothelium),3E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Na,6.022E+17,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|R*T,928.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Age,30,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gestational age,40,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fraction endosomal (global),0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Protein ratio (interstial/plasma),0.37,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (lipid, blood cells),0.005,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (lipid, plasma),0.007,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral lipid, blood cells)-WS,0.003,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral lipid, plasma)-RR,0.0032,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (protein,blood cells),0.325,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (protein,plasma),0.067,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (water,blood cells),0.625,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (water,interstitial),0.935,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (water,plasma),0.926,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Surface/Volume ratio (blood cells),167000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral lipid, plasma)-PT,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral phospholipid, blood cells)-WS,0.0059,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral phospholipid, plasma)-RR,0.0021,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fraction of endosomal uptake from plasma (global),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Height,17.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Ontogeny factor (albumin),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Ontogeny factor (alpha1-acid glycoprotein),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Plasma protein scale factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (acidic phospholipids, blood cells)-WS,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral lipid, blood cells)-RR,0.0012,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (phospholipid, plasma)-PT,0.00225,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (neutral phospholipid, blood cells)-RR,0.0033,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (water,plasma)-PT,0.945,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fraction recycled to plasma (global),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Acidic phospholipids (blood cells) [mg/g] - RR,0.57,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Vf (intracellular water, blood cells)-RR,0.63,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Rate constant for endosomal uptake (global),0.294,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Rate constant for recycling from endosomal space (global),0.0888,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Hematocrit,0.47,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanBW,73,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanHeight,17.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Hematocrit|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Hematocrit|Mean,0.47,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanBW|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanBW|Mean,73,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanBW|Deviation,3.65,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanHeight|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanHeight|Mean,17.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|MeanHeight|Deviation,0.88,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Weight (tissue),0.964012058164037,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Fraction vascular,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Volume,0.964012058164037,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Volume|Percentile,0.501054043959735,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Volume|Mean,0.963884723,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Volume|Deviation,0.048194236,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Volume of protein container,0.51092639082694,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Volume,0.51092639082694,(1-HCT)*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Start amount,1.99785319492248E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Volume of protein container,0.453085667337097,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Volume,0.453085667337097,HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Start amount,1.77168113511994E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|VenousBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Weight (tissue),0.419106233649973,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Peripheral blood flow fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Fraction vascular,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Volume,0.419106233649973,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Volume|Percentile,0.500493470602675,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Volume|Mean,0.419080314,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Volume|Deviation,0.020954016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Volume of protein container,0.222126303834486,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Volume,0.222126303834486,(1-HCT)*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Start amount,8.68570803465044E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Volume of protein container,0.196979929815487,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Volume,0.196979929815487,HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Start amount,7.70242033261454E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|ArterialBlood|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Weight (tissue),11.8190154747065,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Blood flow rate,0.324963830477054,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Fluid recirculation flow rate,5.33269762877872E-06,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Lymph flow rate,0.000114016809561179,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Volume (endothelium),0.0114526259949906,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Fraction intracellular,0.866,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Fluid recirculation flow proportionality factor,0.96,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Lymph flow proportionality factor,0.000662,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Organ volume mouse,0.00158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Peripheral blood flow fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Allometric scale factor,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Hydraulic conductivity,9E-12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Fraction vascular,0.034,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (lipid),0.268,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (neutral lipid)-PT,0.074,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (phospholipid)-PT,0.0011,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (protein),0.268,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Fraction interstitial,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Albumin ratio (tissue/plasma),0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Lipoprotein ratio (tissue/plasma),0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (water),0.465,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (water)-PT,0.439,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (neutral lipid)-RR,0.0174,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (neutral lipid)-WS,0.017,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (neutral phospholipid)-RR,0.0016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (neutral phospholipid, plasma)-WS,0.0022,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (extracellular water)-RR,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (protein)-WS,0.21,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (intracellular water)-RR,0.317,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (water)-WS,0.26,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Acidic phospholipids [mg/g] - RR,0.67,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Vf (acidic phospholipids)-WS,0.0008,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Specific blood flow rate,0.027495,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Volume,11.8190154747065,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Specific blood flow rate|Mean,0.027495,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Specific blood flow rate|Deviation,0.00137475,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Volume|Percentile,0.503623887688135,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Volume|Mean,11.817828072,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Volume|Deviation,0.130693360648248,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Volume of protein container,0.21297865885421,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Volume,0.21297865885421,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Start amount,8.32801166041773E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Volume of protein container,0.188867867285809,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Volume,0.188867867285809,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Start amount,7.38521788754025E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Volume of protein container,1.18190154747065,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Volume,1.18190154747065,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Relative expression,0.0062154033171,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Relative expression (normalized),0.0062154033171,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Relative expression out.,0.053825392726086,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Start amount,0.030320626091752,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Concentration,0.0256541047404839,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Volume of protein container,11.8190154747065,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Volume,10.2352674010958,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Relative expression,0.0341950646,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Relative expression (normalized),0.0242518188652482,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Relative expression out.,0.0242518188652482,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Start amount,0.404151997665987,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Concentration,0.0394862177829099,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Relative expression,4.8717948718E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Relative expression (normalized),4.8717948718E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Relative expression out.,4.8717948718E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Start amount,0.000575798189793997,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Concentration,5.62562918221709E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam|Partition coefficient (water/container),0.0345547006201094,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Itraconazole|Partition coefficient (water/container),0.00132732165053113,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0102515381194494,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00339415924835889,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000366426279369338,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Bone|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Time to complete gallbladder refilling,118.2,6*EHC_HalfTime,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Gallbladder emptying active,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Gallbladder ejection half-time,19.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Gallbladder ejection fraction,0.65,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gallbladder|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Weight (tissue),1.5090801333495,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Fluid recirculation flow rate,5.5864553533426E-07,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Lymph flow rate,3.00471349498978E-05,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Volume (endothelium),0.00167734256821797,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Fraction intracellular,0.957,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Blood flow rate,0.779817158908353,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Fluid recirculation flow proportionality factor,0.404,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Lymph flow proportionality factor,7.27E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Organ volume mouse,0.00017,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Allometric scale factor,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Hydraulic conductivity,5E-14,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Fraction vascular,0.039,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (lipid),0.11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (neutral lipid)-PT,0.051,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (phospholipid)-PT,0.0565,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (protein),0.081,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Fraction interstitial,0.004,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Albumin ratio (tissue/plasma),0.048,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Lipoprotein ratio (tissue/plasma),0.041,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (water),0.808,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (water)-PT,0.77,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (neutral lipid)-RR,0.0391,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (neutral lipid)-WS,0.0429,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (neutral phospholipid)-RR,0.0015,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (neutral phospholipid, plasma)-WS,0.0528,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (extracellular water)-RR,0.162,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (protein)-WS,0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (intracellular water)-RR,0.591,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (water)-WS,0.79,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Acidic phospholipids [mg/g] - RR,0.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Vf (acidic phospholipids)-WS,0.0143,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Volume,1.5090801333495,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Specific blood flow rate,0.51675,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Volume|Percentile,0.501481386141927,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Volume|Mean,1.5088,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Volume|Deviation,0.07544,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Specific blood flow rate|Mean,0.51675,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Specific blood flow rate|Deviation,0.0258375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Volume of protein container,0.0311926863563341,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Volume,0.0311926863563341,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Start amount,1.21971401779333E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Relative expression,0.00014166666667,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Relative expression (normalized),0.00014166666667,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Relative expression out.,0.00014166666667,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Start amount,4.41896390058464E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Concentration,0.00014166666667,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Volume of protein container,0.0276614388442963,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Volume,0.0276614388442963,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Start amount,1.08163318559031E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Volume of protein container,0.00603632053339799,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Volume,0.00603632053339799,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Relative expression,0.1072855464,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Relative expression (normalized),0.07608904,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Relative expression out.,0.07608904,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Start amount,0.000647609946671143,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Concentration,0.1072855464,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Relative expression out.,239.25,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Start amount,0.688325558528779,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Concentration,114.030650745,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Volume of protein container,1.5090801333495,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Volume,1.44418968761547,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|pH,7.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Relative expression,0.0041682898325,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Relative expression (normalized),0.0041682898325,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Relative expression out.,0.0041682898325,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Start amount,0.0271740241854797,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Concentration,0.0188161045730408,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Relative expression,3.9743589744E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Relative expression (normalized),3.9743589744E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Relative expression out.,3.9743589744E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Start amount,5.99762617106633E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Concentration,4.15293518746082E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam|Partition coefficient (water/container),0.0185083230864735,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Itraconazole|Partition coefficient (water/container),0.000600375251451651,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00478361124895375,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.0015500030275223,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000165660866673609,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Brain|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Weight (tissue),14.6539132819426,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fluid recirculation flow rate,1.77820871157669E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Lymph flow rate,0.00127894970673941,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Volume (endothelium),0.00751745751363656,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fraction intracellular,0.822,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Blood flow rate,0.320041466077627,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fluid recirculation flow proportionality factor,0.357,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Lymph flow proportionality factor,0.00754,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Organ volume mouse,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Peripheral blood flow fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Allometric scale factor,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Hydraulic conductivity,9E-12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fraction vascular,0.018,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (protein),0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Albumin ratio (tissue/plasma),0.049,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Albumin ratio (tissue/plasma)-PT,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Lipoprotein ratio (tissue/plasma),0.068,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (protein)-WS,0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Acidic phospholipids [mg/g] - RR,0.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (acidic phospholipids)-WS,0.000552,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Volume,14.6539132819426,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (lipid),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-PT,0.79,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (phospholipid)-PT,0.002,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fraction interstitial,0.16,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water),0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)-PT,0.18,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-RR,0.853,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-WS,0.92,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral phospholipid)-RR,0.0016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral phospholipid, plasma)-WS,0.002024,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (extracellular water)-RR,0.135,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (intracellular water)-RR,0.00899999999999998,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)-WS,0.03,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Specific blood flow rate,0.02184,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Volume|Percentile,0.485732491647913,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Volume|Mean,14.868,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Volume|GeometricDeviation,1.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (lipid)|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (lipid)|Mean,0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-PT|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-PT|Mean,0.79,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (phospholipid)-PT|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (phospholipid)-PT|Mean,0.002,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fraction interstitial|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Fraction interstitial|Mean,0.16,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)|Mean,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)-PT|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)-PT|Mean,0.18,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-RR|Mean,0.853,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral lipid)-WS|Mean,0.92,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral phospholipid)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral phospholipid)-RR|Mean,0.0016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral phospholipid, plasma)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (neutral phospholipid, plasma)-WS|Mean,0.002024,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (extracellular water)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (extracellular water)-RR|Mean,0.135,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (intracellular water)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (intracellular water)-RR|Mean,0.00899999999999998,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Vf (water)-WS|Mean,0.03,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Specific blood flow rate|Mean,0.02184,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Specific blood flow rate|Deviation,0.001092,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Volume of protein container,0.139798332709733,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Volume,0.139798332709733,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Start amount,5.46647326627484E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Volume of protein container,0.123972106365235,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Volume,0.123972106365235,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Start amount,4.84762723613052E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Volume of protein container,2.34462612511082,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Volume,2.34462612511082,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Relative expression out.,0,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Volume of protein container,14.6539132819426,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Volume,12.0455167177568,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|pH,7.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam|Partition coefficient (water/container),0.0087376430833737,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Itraconazole|Partition coefficient (water/container),0.00018314900312197,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00187027841885226,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.000528789598627518,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),4.35605060124231E-05,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Fat|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Weight (tissue),0.040269057138985,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Fluid recirculation flow rate,3.20596455120278E-06,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Lymph flow rate,1.90943707697811E-05,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Volume (endothelium),6.3121747065359E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Fraction intracellular,0.876,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Blood flow rate,0.00324568600540219,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Fluid recirculation flow proportionality factor,0.96,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Lymph flow proportionality factor,0.0111,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Organ volume mouse,0.00025,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Hydraulic conductivity,9E-12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Fraction vascular,0.055,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (lipid),0.031,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (neutral lipid)-PT,0.0048,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (phospholipid)-PT,0.01405,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (protein),0.12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Fraction interstitial,0.069,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Albumin ratio (tissue/plasma),0.048,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Lipoprotein ratio (tissue/plasma),0.041,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (water)-PT,0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (neutral lipid)-RR,0.0048,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (neutral lipid)-WS,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (neutral phospholipid)-RR,0.0116,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (neutral phospholipid, plasma)-WS,0.0249,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (extracellular water)-RR,0.03,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (protein)-WS,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (intracellular water)-RR,0.83,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Acidic phospholipids [mg/g] - RR,2.45,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Vf (acidic phospholipids)-WS,0.0054,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Volume,0.040269057138985,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Specific blood flow rate,0.0806,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Volume|Percentile,0.500178840021776,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Volume|Mean,0.040268154912,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Volume|Deviation,0.0020134077456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Specific blood flow rate|Mean,0.0806,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Specific blood flow rate|Deviation,0.00403,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Volume of protein container,0.00117384301560141,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Volume,0.00117384301560141,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Start amount,4.59002717644131E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Volume of protein container,0.00104095512704276,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Volume,0.00104095512704276,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Start amount,4.07040145835361E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Volume of protein container,0.00277856494258996,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Volume,0.00277856494258996,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Relative expression,0.0141666667,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Relative expression (normalized),0.0141666667,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Relative expression out.,0.0141666667,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Start amount,3.93630034459767E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Concentration,0.0141666667,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Relative expression,0.0508741242,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Relative expression (normalized),0.0508741242,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Relative expression out.,0.645880185495652,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Start amount,0.000855346671104914,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Concentration,0.307837566793607,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Volume of protein container,0.040269057138985,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Volume,0.0352756940537509,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Relative expression,0.024559342,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Relative expression (normalized),0.0174179730496454,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Relative expression out.,0.0174179730496454,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Start amount,0.000988981546293874,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Concentration,0.0280357785388128,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Relative expression,0.00078691079081,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Relative expression (normalized),0.00078691079081,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Relative expression out.,0.00078691079081,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Start amount,0.000136892832185139,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Concentration,0.00388065595467945,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Relative expression,0.0011923076923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Relative expression (normalized),0.0011923076923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Relative expression out.,0.0011923076923,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Start amount,4.801310658848E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Concentration,0.00136108184052511,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam|Partition coefficient (water/container),0.0702918971065179,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Itraconazole|Partition coefficient (water/container),0.00286065760894775,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0217812063385726,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00729004359605516,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.00079084625465072,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Gonads|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Weight (tissue),0.41762674186425,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Fluid recirculation flow rate,1.13231631050175E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Lymph flow rate,0.000202821256175456,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Volume (endothelium),0.00166633070003836,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Fraction intracellular,0.76,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Blood flow rate,0.260327629541081,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Fluid recirculation flow proportionality factor,0.96,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Lymph flow proportionality factor,0.00147,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Organ volume mouse,9.5E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Hydraulic conductivity,1.43333333333333E-11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Fraction vascular,0.14,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (lipid),0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (neutral lipid)-PT,0.0115,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (phospholipid)-PT,0.0166,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (protein),0.168,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Fraction interstitial,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Albumin ratio (tissue/plasma),0.157,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Lipoprotein ratio (tissue/plasma),0.16,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (water),0.731,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (water)-PT,0.758,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (neutral lipid)-RR,0.0135,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (neutral lipid)-WS,0.0528,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (neutral phospholipid)-RR,0.0106,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (neutral phospholipid, plasma)-WS,0.0473,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (extracellular water)-RR,0.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (protein)-WS,0.19,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (intracellular water)-RR,0.248,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (water)-WS,0.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Acidic phospholipids [mg/g] - RR,2.25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Vf (acidic phospholipids)-WS,0.0099,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Volume,0.41762674186425,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Specific blood flow rate,0.62335,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Volume|Percentile,0.50212935157172,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Volume|Mean,0.4171997376,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Volume|Deviation,0.079998771064368,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Specific blood flow rate|Mean,0.62335,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Specific blood flow rate|Deviation,0.0311675,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Volume of protein container,0.0309879042463274,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Volume,0.0309879042463274,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Start amount,1.21170651220964E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Volume of protein container,0.0274798396146677,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Volume,0.0274798396146677,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Start amount,1.0745321900727E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Volume of protein container,0.041762674186425,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Volume,0.041762674186425,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Relative expression,0.0008253968254,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Relative expression (normalized),0.0008253968254,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Relative expression out.,0.0008253968254,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Start amount,3.44707786936898E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Concentration,0.0008253968254,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Relative expression,0.3179118843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Relative expression (normalized),0.3179118843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Relative expression out.,2.41613032068,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Start amount,0.0480926060999337,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Concentration,1.15156912330978,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Volume of protein container,0.41762674186425,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Volume,0.31739632381683,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|pH,7.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Relative expression,0.059106933,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Relative expression (normalized),0.0419198106382979,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Relative expression out.,0.0419198106382979,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Start amount,0.0246846358503785,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Concentration,0.0777722802631579,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Relative expression,0.0026602564103,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Relative expression (normalized),0.0026602564103,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Relative expression out.,0.0026602564103,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Start amount,0.00111099421715708,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Concentration,0.00350033738197368,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam|Partition coefficient (water/container),0.0324832803835989,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Itraconazole|Partition coefficient (water/container),0.00142192056833128,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0106843363920958,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00360518736547071,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000392759286818795,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Heart|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Weight (tissue),0.438416583654993,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Fluid recirculation flow rate,3.32025203942405E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Lymph flow rate,0.000498687718700374,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Volume (endothelium),0.00287382070585848,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Fraction intracellular,0.57,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|GFR,0.116618811252228,GFRspec * Weight_Kidney,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|GFR (specific),0.266,(PMA^Hill/(TM50^Hill+PMA^Hill)*(1-GFR_premat)+GFR_premat) * GFR_mat / V_kid_std * Renal_aging_scaling_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Renal aging scaling factor,1,Age <= Age_onset ? 1 : 1 - Decrease_Factor*(Age-Age_onset)^Hill/(TA50^Hill+(Age-Age_onset)^Hill),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Blood flow rate,1.32710891955285,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Fluid recirculation flow proportionality factor,0.761,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Lymph flow proportionality factor,0.000709,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Organ volume mouse,0.00034,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Volume (standard kidney),0.44,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hydraulic conductivity,1.25E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Fraction vascular,0.23,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (lipid),0.052,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (neutral lipid)-PT,0.0207,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (phospholipid)-PT,0.0162,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (protein),0.171,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Fraction interstitial,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Albumin ratio (tissue/plasma),0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Lipoprotein ratio (tissue/plasma),0.137,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (water),0.774,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (water)-PT,0.783,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (neutral lipid)-RR,0.0121,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (neutral lipid)-WS,0.0156,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (neutral phospholipid)-RR,0.024,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (neutral phospholipid, plasma)-WS,0.0366,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (extracellular water)-RR,0.273,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (protein)-WS,0.21,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (intracellular water)-RR,0.399,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (water)-WS,0.73,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Acidic phospholipids [mg/g] - RR,5.03,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Vf (acidic phospholipids)-WS,0.0078,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|fGFRpremat,0.258,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Volume,0.438416583654993,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Age of aging onset,30,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Aging half-time,54,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|GFRmat,0.11704,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for aging GFR,1.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for GFR,15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Maximal decreasing rate factor,0.9,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|TM50 for GFR,44.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Specific blood flow rate,3.02705,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Volume|Percentile,0.502577830937475,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Volume|Mean,0.43771998528,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Volume|Deviation,0.107804039048952,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Age of aging onset|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Age of aging onset|Mean,30,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Aging half-time|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Aging half-time|Mean,54,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|GFRmat|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|GFRmat|Mean,0.11704,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|GFRmat|Deviation,0.026708,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for aging GFR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for aging GFR|Mean,1.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for GFR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for GFR|Mean,15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Hill coefficient for GFR|Deviation,0.257,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Maximal decreasing rate factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Maximal decreasing rate factor|Mean,0.9,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|TM50 for GFR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|TM50 for GFR|Mean,44.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|TM50 for GFR|Deviation,1.04,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Specific blood flow rate|Mean,3.02705,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Specific blood flow rate|Deviation,0.1513525,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Volume of protein container,0.0534429815475437,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Volume,0.0534429815475437,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Start amount,2.08975761181827E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Volume of protein container,0.0473928326931048,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Volume,0.0473928326931048,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Start amount,1.85318127840488E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Volume of protein container,0.0876833167309987,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Volume,0.0876833167309987,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Relative expression,0.0158938619,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Relative expression (normalized),0.0158938619,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Relative expression out.,0.045297506415,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Start amount,0.00189304492522827,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Concentration,0.021589567956649,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Volume of protein container,0.438416583654993,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Volume,0.249897452683346,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|pH,7.22,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Relative expression (normalized),0.709219858156028,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Relative expression out.,0.709219858156028,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Start amount,0.438416583654993,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Concentration,1.75438596491228,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Relative expression,0.0053603428126,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Relative expression (normalized),0.0053603428126,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Relative expression out.,0.0053603428126,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Start amount,0.0101522729510771,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Concentration,0.0406257560533895,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Relative expression,5.7051282051E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Relative expression (normalized),5.7051282051E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Relative expression out.,5.7051282051E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Start amount,2.50122281699369E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Concentration,0.000100089968510526,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam|Partition coefficient (water/container),0.0305550380632884,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Itraconazole|Partition coefficient (water/container),0.00122917114022927,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00940157237128465,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00313410092182372,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000339439055313859,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Urine|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Urine|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Urine|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Urine|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Urine|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Kidney|Urine|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|OralApplicationsEnabled,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Paracellular absorption sink condition,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Transcellular absorption sink condition,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Effective surface area variability factor,1.00000000260982,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Effective surface area variability factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Effective surface area variability factor|Mean,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Effective surface area variability factor|GeometricDeviation,1.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Absorption of liquid,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Fraction of geometric volume filled with liquid,0.030169,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Geometric surface area,6.28318530717959,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET of non-disintegrated moiety,60,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Intestinal transit rate (absolute),0.0666666664926786,1/GET,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Liquid,0.0473893543830752,V*SteadyStateFillLevel,OralApplicationsEnabled ? -LT_sto + Inflow*FillLevelFlag : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Liquid transfer rate,0.00315929028395984,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|pH,2,pH_fasted,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Secretion of liquid,0.00315929029220502,SteadyStateFillLevel*V/StomachInflowTime,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Volume,1.5707963267949,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Volume (gut wall),0.142427244543147,Area*d,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Volume of protein container,1.5707963267949,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Fractional steady state fill level,0.030169,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|pH in fed state,5.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Thickness of gut wall,0.022668,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Inverse rate of inflow of liquid into stomach,15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|pH in fasted state,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Distal radius,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Gastric emptying time,15.0000000391473,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_alpha (Weibull function) variability factor,1.00000002079922,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_beta (Weibull function) variability factor,0.999999963215789,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Length,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Proximal radius,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Distal radius|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Distal radius|Mean,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Gastric emptying time|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Gastric emptying time|Mean,15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Gastric emptying time|GeometricDeviation,1.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_alpha (Weibull function) variability factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_alpha (Weibull function) variability factor|Mean,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_alpha (Weibull function) variability factor|GeometricDeviation,1.74,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_beta (Weibull function) variability factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_beta (Weibull function) variability factor|Mean,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|GET_beta (Weibull function) variability factor|GeometricDeviation,1.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Length|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Length|Mean,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Proximal radius|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Proximal radius|Mean,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_F1,7.07895669208657E-05,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K1,7.07895669208657E-05,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K2,0.999929210433079,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|Solubility,0.0316476199106141,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam|Solubility_pKa_pH_Factor,0.00107071877735394,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_F1,0.0195623038725795,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K1,0.0195623038725795,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K2,0.98043769612742,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|Solubility,3.35354092684258E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole|Solubility_pKa_pH_Factor,0.0205427415687069,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.0195623038725795,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.0195623038725795,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.98043769612742,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|Solubility,4.86546336292284E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.0205427415687069,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.0195623038725795,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.0195623038725795,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.98043769612742,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|Solubility,4.86546336292284E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.0205427415687069,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.0306534300317155,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999999998903522,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.0306534299981047,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.969346568905417,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,3.36108190582128E-11,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,1.06286742247748E-09,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|Solubility,3.16093274004728E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.0316227776299111,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Stomach|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Absorption of liquid,-0.881716648412967,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Distal radius,0.1608833079,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Effective surface area,697.637922302124,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Fraction of geometric volume filled with liquid,0.06,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Geometric surface area,2.38355247026073,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Intestinal transit rate (absolute),1.62619861602195,LuminalVelocity/SITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Length,2.252366346,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Liquid,0.0120515229563923,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_sto - LT_duo + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Liquid transfer rate,0.0195981699526418,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Proximal radius,0.1759661202,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Secretion of liquid,0.00581285123929987,0.02894*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Thickness of gut wall,0.0252518777358106,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Volume,0.200858715939871,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Volume (gut wall),0.0630347713635856,V_Intestine * 0.087,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Volume of protein container,0.200858715939871,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Fractional steady state fill level,0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Intestinal transit rate,116,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|L_p0,-0.0289872252,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|L_p1,0.129622362,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Microvilli factor,25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|r1_p0,-0.002264627,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|r1_p1,0.010126747,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|r2_p0,-0.0020705161,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|r2_p1,0.00925874,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Thickness_p1,-0.0186500479,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Thickness_p2,0.0441002752,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Thickness_p3,-0.30705627,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|pH,6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Effective surface area enhancement factor,292.6883,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Effective surface area enhancement factor|Mean,292.6883,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_F1,0.41450132132819,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K1,0.41450132132819,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K2,0.58549867867181,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|Solubility,8.16352128364251E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam|Solubility_pKa_pH_Factor,0.415086820006862,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_F1,0.995013121263312,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K1,0.995013121263312,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K2,0.00498687873668791,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|Solubility,6.92358501181912E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole|Solubility_pKa_pH_Factor,0.995018108142049,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.995013121263312,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.995013121263312,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00498687873668791,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|Solubility,1.00450389453884E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.995018108142049,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.995013121263312,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.995013121263312,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00498687873668791,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|Solubility,1.00450389453884E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.995018108142049,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.99684769081674,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999989035338264,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.996836760719007,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00315227461925627,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,1.09300977324518E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.45640038827887E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|Solubility,1.0027434423201E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.996839958487728,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Duodenum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Absorption of liquid,0.738519260697634,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Distal radius,0.1508281056,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Effective surface area,2285.01702047842,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Fraction of geometric volume filled with liquid,0.064841,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Geometric surface area,5.10062444686524,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Intestinal transit rate (absolute),0.0703218749800801,LuminalVelocity/SITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Length,5.208597173,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Liquid,0.0257819866318681,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_duo - LT_uje + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Liquid transfer rate,0.00181303764066433,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Proximal radius,0.1608833079,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Secretion of liquid,0.00125536139470604,0.0031572*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Thickness of gut wall,0.0337735795268098,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Volume,0.397618584412149,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Volume (gut wall),0.180409862868193,V_Intestine * 0.249,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Volume of protein container,0.397618584412149,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Fractional steady state fill level,0.064841,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Intestinal transit rate,5.0162,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|L_p0,-0.0670329582,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|L_p1,0.299751712,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Microvilli factor,25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|r1_p0,-0.0020705161,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|r1_p1,0.00925874,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|r2_p0,-0.0019411088,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|r2_p1,0.008680069,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Thickness_p1,-0.024936327,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Thickness_p2,0.0589752766,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Thickness_p3,-0.30703115,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|pH,6.25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Effective surface area enhancement factor,447.9877,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Effective surface area enhancement factor|Mean,447.9877,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_F1,0.557311633762293,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K1,0.557311633762293,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K2,0.442688366237707,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|Solubility,6.07538114048829E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam|Solubility_pKa_pH_Factor,0.55775432212853,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_F1,0.99718953802679,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K1,0.99718953802679,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K2,0.00281046197321022,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|Solubility,6.9084890898544E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole|Solubility_pKa_pH_Factor,0.997192348488763,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.99718953802679,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.99718953802679,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00281046197321022,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|Solubility,1.00231371237464E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.997192348488763,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.99718953802679,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.99718953802679,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00281046197321022,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|Solubility,1.00231371237464E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.997192348488763,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.99822487725419,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999980501934184,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.998205413799835,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00177508813434969,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,1.94634543554534E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46114601285363E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|Solubility,1.00136994443084E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.998207242962884,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Absorption of liquid,0.0487432162951318,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Distal radius,0.1407729032,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Effective surface area,1779.48258579791,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Fraction of geometric volume filled with liquid,0.064841,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Geometric surface area,4.77155205038986,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Intestinal transit rate (absolute),0.0703218749800801,LuminalVelocity/SITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Length,5.208597173,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Liquid,0.0225637095370335,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_uje - LT_lje + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Liquid transfer rate,0.00158672236115011,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Proximal radius,0.1508281056,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Secretion of liquid,0.000873512494869936,0.0025102*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Thickness of gut wall,0.0266783683244172,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Volume,0.347985218257484,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Volume (gut wall),0.133314918745974,V_Intestine * 0.184,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Volume of protein container,0.347985218257484,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Fractional steady state fill level,0.064841,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Intestinal transit rate,5.0162,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|L_p0,-0.0670329582,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|L_p1,0.299751712,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Microvilli factor,25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|r1_p0,-0.0019411088,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|r1_p1,0.008680069,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|r2_p0,-0.0018117016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|r2_p1,0.008101398,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Thickness_p1,-0.0196976609,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Thickness_p2,0.0465856499,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Thickness_p3,-0.30703115,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|pH,6.9167,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Effective surface area enhancement factor,372.9358,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Effective surface area enhancement factor|Mean,372.9358,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_F1,0.853883683643945,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K1,0.853883683643945,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K2,0.146116316356055,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|Solubility,3.96774221443212E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam|Solubility_pKa_pH_Factor,0.854029799960301,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_F1,0.999393212821241,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K1,0.999393212821241,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K2,0.000606787178759394,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|Solubility,6.89327102575057E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole|Solubility_pKa_pH_Factor,0.999393819608419,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.999393212821241,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.999393212821241,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.000606787178759394,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|Solubility,1.00010580929646E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.999393819608419,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.999393212821241,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.999393212821241,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.000606787178759394,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|Solubility,1.00010580929646E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.999393819608419,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999617057420559,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999909497475545,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999526589553374,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000382907922170998,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,9.04678671843671E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46572701605534E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|Solubility,1.00004765636658E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.999527097586434,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerJejunum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Absorption of liquid,0.0570818420996891,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Distal radius,0.1206624809,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Effective surface area,1658.15372565961,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Fraction of geometric volume filled with liquid,0.064841,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Geometric surface area,6.35910470469577,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Intestinal transit rate (absolute),0.0473069588772936,LuminalVelocity/SITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Length,7.7425093078,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Liquid,0.0270026140608501,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_lje - LT_uil + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Liquid transfer rate,0.00127741155295607,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Proximal radius,0.1407729032,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Secretion of liquid,0.00123204814390625,0.0029585*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Thickness of gut wall,0.0352492706383363,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Volume,0.416443516615261,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Volume (gut wall),0.234750183009215,V_Intestine * 0.324,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Volume of protein container,0.416443516615261,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Fractional steady state fill level,0.064841,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Intestinal transit rate,3.3745,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|L_p0,-0.0996435866,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|L_p1,0.445576869,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Microvilli factor,25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|r1_p0,-0.0018117016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|r1_p1,0.008101398,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|r2_p0,-0.0015528871,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|r2_p1,0.006944055,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Thickness_p1,-0.0260258863,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Thickness_p2,0.061552122,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Thickness_p3,-0.30703115,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|pH,7.2083,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Effective surface area enhancement factor,260.7527,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Effective surface area enhancement factor|Mean,260.7527,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_F1,0.91959269389056,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K1,0.91959269389056,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K2,0.0804073061094398,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|Solubility,3.68453756587676E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam|Solubility_pKa_pH_Factor,0.91967310119667,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_F1,0.999689854642498,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K1,0.999689854642498,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K2,0.000310145357502178,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|Solubility,6.89122760498783E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole|Solubility_pKa_pH_Factor,0.999690164787855,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.999689854642498,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.999689854642498,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.000310145357502178,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|Solubility,9.998093409046E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.999690164787855,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.999689854642498,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.999689854642498,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.000310145357502178,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|Solubility,9.998093409046E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.999690164787855,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999804289108372,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.99982289815775,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999627221926881,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000195676230868387,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,0.000177067181490827,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46607594557363E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|Solubility,9.99947082380184E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.999627629331053,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|UpperIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Absorption of liquid,0.0459460674607501,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Distal radius,0.1005520763,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Effective surface area,788.634160322344,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Fraction of geometric volume filled with liquid,0.064841,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Geometric surface area,5.380780938588,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Intestinal transit rate (absolute),0.0473069588772936,LuminalVelocity/SITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Length,7.7425093078,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Liquid,0.019348329927017,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_uil - LT_lil + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Liquid transfer rate,0.000915310648201703,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Proximal radius,0.1206624809,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Secretion of liquid,0.00052687876732521,0.0017657*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Thickness of gut wall,0.0200575758678131,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Volume,0.298396538101155,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Volume (gut wall),0.113027865893326,V_Intestine * 0.156,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Volume of protein container,0.298396538101155,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Fractional steady state fill level,0.064841,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Intestinal transit rate,3.3745,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|L_p0,-0.0996435866,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|L_p1,0.445576869,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Microvilli factor,25,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|pH,7.4583,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|r1_p0,-0.0015528871,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|r1_p1,0.006944055,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|r2_p0,-0.0012940725,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|r2_p1,0.005786713,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Thickness_p1,-0.0148137399,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Thickness_p2,0.0350288649,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Thickness_p3,-0.30705627,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Effective surface area enhancement factor,146.565,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Effective surface area enhancement factor|Mean,146.565,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_F1,0.953134403840196,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K1,0.953134403840196,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K2,0.0468655961598043,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|Solubility,3.55501120126843E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam|Solubility_pKa_pH_Factor,0.953181269436356,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_F1,0.999825568771748,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K1,0.999825568771748,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K2,0.000174431228251781,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|Solubility,6.89029314043411E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole|Solubility_pKa_pH_Factor,0.999825743202976,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.999825568771748,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.999825568771748,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.000174431228251781,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|Solubility,9.99673764713664E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.999825743202976,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.999825568771748,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.999825568771748,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.000174431228251781,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|Solubility,9.99673764713664E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.999825743202976,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999889934250213,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999685106843655,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.99957507575282,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000110031090835203,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,0.000314858497393342,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46589513557352E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|Solubility,9.99999195773482E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.99957553530136,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|LowerIleum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Absorption of liquid,0.694085095490314,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Distal radius,0.3430963586,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Effective surface area,2.28204581730992,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Fraction of geometric volume filled with liquid,0.0060009,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Geometric surface area,1.2678032285301,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Intestinal transit rate (absolute),0.00723156893249226,LuminalVelocity/LITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Length,0.5881063603,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Liquid,0.00130513175379201,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_lil - LT_cae + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Liquid transfer rate,9.43815024353147E-06,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Proximal radius,0.3430963586,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Secretion of liquid,0,0*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Thickness of gut wall,0.0266806331014496,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Volume,0.217489335565001,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Volume (gut wall),0.0349537987097245,V_Intestine * 0.08470588,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Volume of protein container,0.217489335565001,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Fractional steady state fill level,0.0060009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Intestinal transit rate,18.3333,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|L_p0,0.1152851235,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|L_p1,0.026864843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Microvilli factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|r1_p0,0.067256381,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|r1_p1,0.015672726,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|r2_p0,0.067256381,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|r2_p1,0.015672726,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Thickness_p1,-0.00877,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Thickness_p2,0.0446435379,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Thickness_p3,-0.0897885,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|pH,5.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Effective surface area enhancement factor,1.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Effective surface area enhancement factor|Mean,1.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_F1,0.261890967459581,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K1,0.261890967459581,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K2,0.738109032540419,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|Solubility,0.000129024940229234,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam|Solubility_pKa_pH_Factor,0.262629076492122,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|Solubility,6.95791380548306E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole|Solubility_pKa_pH_Factor,0.990108910891089,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|Solubility,1.00948446556836E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.990108910891089,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|Solubility,1.00948446556836E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.990108910891089,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.993729987658566,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999994504621461,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.993724526736118,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00626997788534261,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,5.4609224478499E-06,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.44560912610767E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|Solubility,1.00588076224443E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.993730836631017,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Caecum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Absorption of liquid,0.162660340501137,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Distal radius,0.3430963586,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Effective surface area,8.86293406514235,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Fraction of geometric volume filled with liquid,0.0060009,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Geometric surface area,3.54517361680467,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Intestinal transit rate (absolute),0.00394449931681272,LuminalVelocity/LITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Length,1.6445289817,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Liquid,0.00364955582686276,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_cae - LT_colasc + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Liquid transfer rate,1.439567046573E-05,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Proximal radius,0.3430963586,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Secretion of liquid,0.000598595513697603,0.00098426*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Thickness of gut wall,0.0168329998029135,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Volume,0.608168079265237,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Volume (gut wall),0.064081967052155,V_Intestine * 0.15529412,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Volume of protein container,0.608168079265237,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Fractional steady state fill level,0.0060009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Intestinal transit rate,10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|L_p0,0.3117189273,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|L_p1,0.075727844,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Microvilli factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|pH,5.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|r1_p0,0.067256381,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|r1_p1,0.015672726,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|r2_p0,0.067256381,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|r2_p1,0.015672726,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Thickness_p1,-0.00554,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Thickness_p2,0.0280138174,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Thickness_p3,-0.09106073,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Effective surface area enhancement factor,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Effective surface area enhancement factor|Mean,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_F1,0.219870396006841,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K1,0.219870396006841,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K2,0.780129603993159,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|Solubility,0.000153571811365725,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam|Solubility_pKa_pH_Factor,0.220650525610834,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_F1,0.987567264745558,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K1,0.987567264745558,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K2,0.0124327352544424,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|Solubility,6.97573317636449E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole|Solubility_pKa_pH_Factor,0.987579697480812,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.987567264745558,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.987567264745558,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.0124327352544424,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|Solubility,1.01206977757335E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.987579697480812,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.987567264745558,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.987567264745558,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.0124327352544424,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|Solubility,1.01206977757335E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.987579697480812,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.99211931614967,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999995634860732,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.992114985410684,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00788064945004772,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.33073898529327E-06,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.44002825323962E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|Solubility,1.00751099141958E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.992122904791156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonAscendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Absorption of liquid,0.0356592369018398,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Distal radius,0.1960550545,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Effective surface area,13.6930569430801,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Fraction of geometric volume filled with liquid,0.0060009,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Geometric surface area,5.47722276293745,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Intestinal transit rate (absolute),0.00131481995727318,LuminalVelocity/LITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Length,3.2337004261,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Liquid,0.00454008377608023,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_colasc - LT_coltrans + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Liquid transfer rate,5.96939275648248E-06,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Proximal radius,0.3430963586,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Secretion of liquid,0.000153469645216197,0.00020285*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Thickness of gut wall,0.0232585538759707,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Volume,0.756567144275064,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Volume (gut wall),0.132047687682506,V_Intestine * 0.32,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Volume of protein container,0.756567144275064,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Fractional steady state fill level,0.0060009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Intestinal transit rate,3.3333,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|L_p0,0.6886041141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|L_p1,0.144607745,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Microvilli factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|pH,5.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|r1_p0,0.067256381,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|r1_p1,0.015672726,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|r2_p0,0.0384322177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|r2_p1,0.008955843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Thickness_p1,-0.0076,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Thickness_p2,0.0394956146,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Thickness_p3,-0.08637087,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Effective surface area enhancement factor,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Effective surface area enhancement factor|Mean,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_F1,0.261890967459581,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K1,0.261890967459581,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K2,0.738109032540419,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|Solubility,0.000129024940229234,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam|Solubility_pKa_pH_Factor,0.262629076492122,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|Solubility,6.95791380548306E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole|Solubility_pKa_pH_Factor,0.990108910891089,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|Solubility,1.00948446556836E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.990108910891089,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|Solubility,1.00948446556836E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.990108910891089,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.993729987658566,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999994504621461,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.993724526736118,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00626997788534261,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,5.4609224478499E-06,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.44560912610767E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|Solubility,1.00588076224443E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.993730836631017,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonTransversum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Absorption of liquid,0.0401817688756915,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Distal radius,0.1960550545,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Effective surface area,6.6415380370092,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Fraction of geometric volume filled with liquid,0.0060009,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Geometric surface area,2.65661520787039,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Intestinal transit rate (absolute),0.00197224965840636,LuminalVelocity/LITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Length,2.1566056703,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Liquid,0.00156276289737139,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_coltrans - LT_coldesc + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Liquid transfer rate,3.08215859051085E-06,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Proximal radius,0.1960550545,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Secretion of liquid,5.99073433837115E-05,0.00023004*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Thickness of gut wall,0.035965107966664,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Volume,0.260421419682279,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Volume (gut wall),0.0990357657618795,V_Intestine * 0.24,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Volume of protein container,0.260421419682279,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Fractional steady state fill level,0.0060009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Intestinal transit rate,5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|L_p0,0.4227543951,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|L_p1,0.098514277,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Microvilli factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|pH,6.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|r1_p0,0.0384322177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|r1_p1,0.008955843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|r2_p0,0.0384322177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|r2_p1,0.008955843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Thickness_p1,-0.0118,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Thickness_p2,0.0601543776,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Thickness_p3,-0.08977747,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Effective surface area enhancement factor,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Effective surface area enhancement factor|Mean,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_F1,0.738109032540418,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K1,0.738109032540418,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K2,0.261890967459582,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|Solubility,4.58925179987718E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam|Solubility_pKa_pH_Factor,0.738370923507878,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|Solubility,6.89775662982192E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|Solubility,1.0007566002886E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|Solubility,1.0007566002886E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999206302221831,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999956350322153,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999162687188637,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000793663133516853,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.3615033194211E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46446523245957E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|Solubility,1.00041151651399E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.999163559111456,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonDescendens|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Absorption of liquid,0.0218151710161709,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Distal radius,0.1960550545,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Effective surface area,8.21854246352471,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Fraction of geometric volume filled with liquid,0.0060009,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Geometric surface area,3.28741697683031,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Intestinal transit rate (absolute),0.00160702846666267,LuminalVelocity/LITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Length,2.6686823413,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Liquid,0.00193383417529163,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_coldesc - LT_colsigm + Inflow*FillLevelFlag - Outflow*Liquid : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Liquid transfer rate,3.10772656949877E-06,w*Liquid*FillLevelFlagNext,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Proximal radius,0.1960550545,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Secretion of liquid,4.22124912298906E-05,0.00013099*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Thickness of gut wall,0.01634327810061,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Volume,0.322257357278346,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Volume (gut wall),0.0557076182410572,V_Intestine * 0.135,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Volume of protein container,0.322257357278346,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Fractional steady state fill level,0.0060009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Intestinal transit rate,4.0741,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|L_p0,0.5337898629,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|L_p1,0.121300709,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Microvilli factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|pH,6.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|r1_p0,0.0384322177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|r1_p1,0.008955843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|r2_p0,0.0384322177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|r2_p1,0.008955843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Thickness_p1,-0.00536,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Thickness_p2,0.0274432593,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Thickness_p3,-0.0889014,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Effective surface area enhancement factor,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Effective surface area enhancement factor|Mean,2.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_F1,0.738109032540418,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K1,0.738109032540418,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K2,0.261890967459582,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|Solubility,4.58925179987718E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam|Solubility_pKa_pH_Factor,0.738370923507878,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|Solubility,6.89775662982192E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|Solubility,1.0007566002886E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|Solubility,1.0007566002886E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999206302221831,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999956350322153,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999162687188637,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000793663133516853,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.3615033194211E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46446523245957E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|Solubility,1.00041151651399E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.999163559111456,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|ColonSigmoid|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Absorption of liquid,0.000144652288070653,(k_p*alpha_p*V_p+inflow-k*alpha*V)/(alpha*V),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Distal radius,0.1225344113,r2_p0 + Height*r2_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Effective surface area,3.84643425864822,Ageom*AeffFactor*AeffVariabilityFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|FillLevelFlag,1,(FillLevel<0.9?1:1/(1+exp((FillLevel-1)/0.01))),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Fraction of geometric volume filled with liquid,0.0060009,Liquid/V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Geometric surface area,1.08045905859824,PI*(r1+r2)*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Intestinal transit rate (absolute),0.12449549853738,LuminalVelocity/LITT_fact,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Length,1.0795108969,L_p0 + Height*L_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Liquid,0.000525578833597355,V*SteadyStateFillLevel,OralApplicationsEnabled ? LT_colsigm - LT_rect + Inflow*FillLevelFlag : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Liquid transfer rate,6.54321989093972E-05,w*Liquid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Proximal radius,0.1960550545,r1_p0 + Height*r1_p1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Secretion of liquid,6.24004985207398E-05,0.00071247*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Thickness of gut wall,0.0202494798532162,Thickness_p1 + Thickness_p2*(1-exp(Thickness_p3*Height)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Volume,0.0875833347660109,PI*(r1*r1+r1*r2+r2*r2)/3*L,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Volume (gut wall),0.0226956963204307,V_Intestine * 0.055,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Volume of protein container,0.0875833347660109,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Fractional steady state fill level,0.0060009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Intestinal transit rate,315.618,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|L_p0,0.1569046761,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|L_p1,0.052420808,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Microvilli factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|pH,6.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|r1_p0,0.0384322177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|r1_p1,0.008955843,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|r2_p0,0.0240201361,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|r2_p1,0.005597402,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Thickness_p1,-0.00665,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Thickness_p2,0.0324721331,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Thickness_p3,-0.10014267,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Effective surface area enhancement factor,3.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Effective surface area enhancement factor|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Effective surface area enhancement factor|Mean,3.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|Ontogeny factor,0.974126058257768,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_F1,0.738109032540418,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K1,0.738109032540418,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K2,0.261890967459582,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|Solubility,4.58925179987718E-05,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam|Solubility_pKa_pH_Factor,0.738370923507878,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|Solubility,6.89775662982192E-07,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|Solubility,1.0007566002886E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|Solubility,1.0007566002886E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.998743914831156,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|Oral mass absorbed segment,0,,PassiveRates_para+PassiveRates_trans-(ActiveRates_para+ActiveRates_trans)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|Partition coefficient (water/container),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999206302221831,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999956350322153,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999162687188637,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000793663133516853,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.3615033194211E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46446523245957E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|Solubility,1.00041151651399E-06,Solubility * Solubility_pKa_REFpH_Factor / Solubility_pKa_pH_Factor + SolubilityTable,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.999163559111456,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Rectum|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|Liquid,0,,OralApplicationsEnabled ? LT_rec : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lumen|Feces|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Weight (tissue),0.168519038333234,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Fluid recirculation flow rate,5.57903782085069E-06,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Lymph flow rate,7.0348494997339E-05,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Volume (endothelium),0.000153689362959909,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Fraction intracellular,0.868,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Blood flow rate,0.0650652007004615,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Fluid recirculation flow proportionality factor,0.96,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Lymph flow proportionality factor,0.00204,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Organ volume mouse,0.00011,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Hydraulic conductivity,3.97222222222222E-11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Fraction vascular,0.032,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (lipid),0.062,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (protein),0.133,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Fraction interstitial,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (water),0.792,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Volume,0.168519038333234,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Specific blood flow rate,0.3861,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Volume|Percentile,0.500668837237195,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Volume|Mean,0.16847666928,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Volume|Deviation,0.025271500392,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Specific blood flow rate|Mean,0.3861,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Specific blood flow rate|Deviation,0.019305,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Volume of protein container,0.00285808289013164,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Volume,0.00285808289013164,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Start amount,1.1175836942306E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Volume of protein container,0.00253452633653183,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Volume,0.00253452633653183,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Start amount,9.91064785449777E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Volume of protein container,0.0168519038333234,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Volume,0.0168519038333234,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Relative expression,0.0309435884,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Relative expression (normalized),0.0309435884,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Relative expression out.,0.268590347312,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Start amount,0.00215729247814357,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Concentration,0.128014763167452,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Volume of protein container,0.168519038333234,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Volume,0.146274525273247,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|pH,7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Relative expression,0.0367802585,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Relative expression (normalized),0.0260852897163121,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Relative expression out.,0.0260852897163121,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Start amount,0.00619817379206774,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Concentration,0.0423735697004608,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Relative expression,0.0775641026,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Relative expression (normalized),0.0775641026,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Relative expression out.,0.0775641026,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Start amount,0.0130710279793323,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Concentration,0.0893595652073733,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Stomach|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time factor,71.3320001979601,P1*SITT+P2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Weight (tissue),0.724537601880294,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fluid recirculation flow rate,9.19847313114238E-06,J_iso_incl_Mucosa-J_iso_duo-J_iso_uje-J_iso_lje-J_iso_uil-J_iso_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fluid recirculation flow rate (incl. mucosa),1.1463700312989E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Lymph flow rate,0.000539348363716187,Q_lymph_incl_Mucosa-Q_lymph_duo-Q_lymph_uje-Q_lymph_lje-Q_lymph_uil-Q_lymph_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Lymph flow rate (incl. mucosa),0.000672168947801829,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Volume (endothelium),0.000397656376676144,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fraction intracellular,0.882,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Blood flow rate,0.650381178327846,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Volume (mucosa),0.143168630131546,V_duo+V_uje+V_lje+V_uil+V_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fluid recirculation flow proportionality factor,0.179,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Lymph flow proportionality factor,0.00195,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Organ volume mouse,0.001406,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa blood flow fraction,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time factor intercept,-4.52,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time factor slope,0.602,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Hydraulic conductivity,1.53888888888889E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fraction vascular,0.024,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (lipid),0.062,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (protein),0.133,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Fraction interstitial,0.094,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (water),0.792,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time,126.000000328837,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Volume,0.724537601880294,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Specific blood flow rate,0.89765,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time|Mean,126,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Small intestinal transit time|GeometricDeviation,1.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Volume|Percentile,0.502072317657916,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Volume|Mean,0.7240974816,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Volume|Deviation,0.084725566517592,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Specific blood flow rate|Mean,0.89765,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Specific blood flow rate|Deviation,0.0448825,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Volume of protein container,0.00739501332064407,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Volume,0.00739501332064407,f_vas*(1-HCT)*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Start amount,2.89163982413024E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Volume of protein container,0.00655784200132588,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Volume,0.00655784200132588,f_vas*HCT*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Start amount,2.56428437234191E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Volume of protein container,0.0546486833443823,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Volume,0.0546486833443823,f_int*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Relative expression,0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Relative expression (normalized),0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Relative expression out.,0.470631374559574,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Start amount,0.0122582997023074,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Concentration,0.224310979736853,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Volume of protein container,0.581368971748748,Volume-V_Mucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Volume,0.512767433082396,f_cell*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|pH,7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Relative expression,0.3960047004,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Relative expression (normalized),0.280854397446809,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Relative expression out.,0.280854397446809,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Start amount,0.230224845479219,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Concentration,0.448984921088435,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Relative expression,0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Relative expression (normalized),0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Relative expression out.,0.0727697702,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Start amount,0.182762293574448,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Concentration,0.356423364244898,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Relative expression,0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Relative expression (normalized),0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Relative expression out.,0.2544871795,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Start amount,0.147950949869154,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Concentration,0.288534217120181,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Weight (tissue),0.0163890405545323,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Volume,0.0163890405545323,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fluid recirculation flow rate,2.59308901079811E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Lymph flow rate,1.52044615992774E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Volume (endothelium),6.0721395254542E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Blood flow rate,0.0453640871883673,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fraction intracellular,0.45,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fraction mucosa,0.26,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fraction of regional blood flow rate,0.093,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Hydraulic conductivity,1.53888888888889E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Fraction interstitial,0.42,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Volume of protein container,0.00112920489420727,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Volume,0.00112920489420727,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Start amount,4.41548067611612E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Volume of protein container,0.00100137037788192,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Volume,0.00100137037788192,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Start amount,3.91561493919731E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Volume of protein container,0.00688339703290354,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Volume,0.00688339703290354,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Relative expression,0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Relative expression (normalized),0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Relative expression out.,0.0537407060357143,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Start amount,0.000176309553015821,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Concentration,0.0256137416123229,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Volume of protein container,0.0163890405545323,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Volume,0.00737506824953951,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Relative expression,1.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Start amount,0.0231085471818905,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Concentration,3.13333333333333,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Relative expression,0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Relative expression (normalized),0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Relative expression out.,0.0727697702,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Start amount,0.00515214740859174,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Concentration,0.69858979392,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Relative expression,0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Relative expression (normalized),0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Relative expression out.,0.2544871795,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Start amount,0.00417080070543403,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Concentration,0.565527065555556,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Weight (tissue),0.0469065643457302,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Volume,0.0469065643457302,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fluid recirculation flow rate,7.42159958262908E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Lymph flow rate,4.35162176806904E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Volume (endothelium),0.000173788820900931,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Blood flow rate,0.106825108540349,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fraction intracellular,0.52,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fraction mucosa,0.26,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fraction of regional blood flow rate,0.219,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Hydraulic conductivity,1.53888888888889E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Fraction interstitial,0.35,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Volume of protein container,0.00323186228342081,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Volume,0.00323186228342081,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Start amount,1.2637410210953E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Volume of protein container,0.00286599108152412,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Volume,0.00286599108152412,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Start amount,1.12067599983923E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Volume of protein container,0.0164172975210056,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Volume,0.0164172975210056,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Relative expression,0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Relative expression (normalized),0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Relative expression out.,0.0745204457028572,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Start amount,0.000583105004456924,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Concentration,0.0355177217024211,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Volume of protein container,0.0469065643457302,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Volume,0.0243914134597797,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Relative expression,1.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Start amount,0.0661382557274796,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Concentration,2.71153846153846,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Relative expression,0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Relative expression (normalized),0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Relative expression out.,0.0727697702,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Start amount,0.0147458012039005,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Concentration,0.604548860123077,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Relative expression,0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Relative expression (normalized),0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Relative expression out.,0.2544871795,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Start amount,0.0119371192603802,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Concentration,0.489398422115385,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Weight (tissue),0.0346618788739533,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Volume,0.0346618788739533,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fluid recirculation flow rate,5.48423422973394E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Lymph flow rate,3.21565624628395E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Volume (endothelium),0.000128422261227997,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Blood flow rate,0.106825108540349,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fraction intracellular,0.55,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fraction mucosa,0.26,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fraction of regional blood flow rate,0.219,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Hydraulic conductivity,1.53888888888889E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Fraction interstitial,0.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Volume of protein container,0.00238820345441538,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Volume,0.00238820345441538,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Start amount,9.33848786672834E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Volume of protein container,0.00211784079919854,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Volume,0.00211784079919854,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Start amount,8.28130056106098E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Volume of protein container,0.011091801239665,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Volume,0.011091801239665,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Relative expression,0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Relative expression (normalized),0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Relative expression out.,0.086209049265625,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Start amount,0.000455747810094537,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Concentration,0.0410887105031013,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Volume of protein container,0.0346618788739533,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Volume,0.0190640333806743,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Relative expression,1.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Start amount,0.0488732492122741,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Concentration,2.56363636363636,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Relative expression,0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Relative expression (normalized),0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Relative expression out.,0.0727697702,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Start amount,0.0108964956687458,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Concentration,0.571573467752727,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Relative expression,0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Relative expression (normalized),0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Relative expression out.,0.2544871795,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Start amount,0.008821003790803,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Concentration,0.462703962727273,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Weight (tissue),0.030517523791198,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Volume,0.030517523791198,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fluid recirculation flow rate,4.82851057183097E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Lymph flow rate,2.8311756081413E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Volume (endothelium),0.000113067425646389,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Blood flow rate,0.11438578973841,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fraction intracellular,0.56,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fraction mucosa,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fraction of regional blood flow rate,0.2345,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Hydraulic conductivity,1.53888888888889E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Fraction interstitial,0.31,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Volume of protein container,0.00210265738921354,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Volume,0.00210265738921354,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Start amount,8.22192953483691E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Volume of protein container,0.0018646207036422,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Volume,0.0018646207036422,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Start amount,7.291145059195E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Volume of protein container,0.00946043237527138,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Volume,0.00946043237527138,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Relative expression,0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Relative expression (normalized),0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Relative expression out.,0.0906079860903226,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Start amount,0.000408551791815972,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Concentration,0.0431853191915293,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Volume of protein container,0.030517523791198,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Volume,0.0170898133230709,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Relative expression,1.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Start amount,0.0430297085455892,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Concentration,2.51785714285714,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Relative expression,0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Relative expression (normalized),0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Relative expression out.,0.0727697702,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Start amount,0.00959365379530877,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Concentration,0.561366798685714,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Relative expression,0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Relative expression (normalized),0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Relative expression out.,0.2544871795,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Start amount,0.00776631855494612,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Concentration,0.454441391964286,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Weight (tissue),0.0146936225661324,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Volume,0.0146936225661324,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fluid recirculation flow rate,2.32483842347417E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Lymph flow rate,1.36315862614211E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Volume (endothelium),5.44398716075204E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Blood flow rate,0.11438578973841,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fraction intracellular,0.55,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fraction mucosa,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fraction of regional blood flow rate,0.2345,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Hydraulic conductivity,1.53888888888889E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Fraction interstitial,0.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Volume of protein container,0.00101239059480652,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Volume,0.00101239059480652,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Start amount,3.95870681306962E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Volume of protein container,0.000897780338790687,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Volume,0.000897780338790687,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Start amount,3.51055132479759E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Volume of protein container,0.00470195922116236,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Volume,0.00470195922116236,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Relative expression,0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Relative expression (normalized),0.0501579923,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Relative expression out.,0.086209049265625,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Start amount,0.000193197441235728,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Concentration,0.0410887105031013,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Volume of protein container,0.0146936225661324,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Volume,0.0080814924113728,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Relative expression,1.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Start amount,0.0207180078182466,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Concentration,2.56363636363636,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Relative expression,0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Relative expression (normalized),0.0727697702,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Relative expression out.,0.0727697702,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Start amount,0.0046191666421857,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Concentration,0.571573467752727,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Relative expression,0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Relative expression (normalized),0.2544871795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Relative expression out.,0.2544871795,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Start amount,0.00373933856349258,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Concentration,0.462703962727273,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Large intestinal transit time factor,2535.176,P1*LITT+P2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Volume (mucosa),0.0839328114831929,V_cae+V_ca+V_ct+V_cd+V_cs+V_rec,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Weight (tissue),0.412649024007831,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fluid recirculation flow rate,2.46867087061925E-05,J_iso_incl_Mucosa-J_iso_cae-J_iso_colasc-J_iso_coltrans-J_iso_coldesc-J_iso_colsigm-J_iso_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fluid recirculation flow rate (incl. mucosa),3.09900937813112E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Lymph flow rate,0.00158177452547946,Q_lymph_incl_Mucosa-Q_lymph_cae-Q_lymph_colasc-Q_lymph_coltrans-Q_lymph_coldesc-Q_lymph_colsigm-Q_lymph_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Lymph flow rate (incl. mucosa),0.00198565719994911,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Volume (endothelium),0.000224841889366853,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fraction intracellular,0.882,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Blood flow rate,0.260175209636938,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fluid recirculation flow proportionality factor,0.179,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Lymph flow proportionality factor,0.0144,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Organ volume mouse,0.000627,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Large intestinal transit time factor intercept,47.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Large intestinal transit time factor slope,0.938,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa blood flow fraction,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fraction vascular,0.024,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (lipid),0.062,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (protein),0.133,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Fraction interstitial,0.094,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (water),0.792,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Large intestinal transit time,2652,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Volume,0.412649024007831,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Specific blood flow rate,0.6305,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Large intestinal transit time|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Large intestinal transit time|Mean,2652,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Volume|Percentile,0.502363701590605,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Volume|Mean,0.41217159744,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Volume|Deviation,0.080576347522488,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Specific blood flow rate|Mean,0.6305,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Specific blood flow rate|Deviation,0.031525,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Volume of protein container,0.0041812702233134,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Volume,0.0041812702233134,f_vas*(1-HCT)*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Start amount,1.63498386939077E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Volume of protein container,0.00370791887727792,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Volume,0.00370791887727792,f_vas*HCT*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Start amount,1.44989135587484E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Volume of protein container,0.030899323977316,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Volume,0.030899323977316,f_int*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Relative expression,0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Relative expression (normalized),0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Relative expression out.,0.738439265795745,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Start amount,0.0108751039295687,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Concentration,0.351952810927268,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Volume of protein container,0.328716212524638,Volume-V_Mucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Volume,0.289927699446731,f_cell*(V-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|pH,7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Relative expression,0.1562867215,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Relative expression (normalized),0.110841646453901,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Relative expression out.,0.110841646453901,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Start amount,0.051373979159373,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Concentration,0.177195829365079,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Relative expression,0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Relative expression (normalized),0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Relative expression out.,0.00010384615385,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Start amount,3.41359143788229E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Concentration,0.00011773940345805,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Weight (tissue),0.00664122175484765,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Volume,0.00664122175484765,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fluid recirculation flow rate,4.98758201355414E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Lymph flow rate,3.19573996950048E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Volume (endothelium),2.46057266017105E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Blood flow rate,0.0165288009806298,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fraction intracellular,0.14,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fraction mucosa,0.19,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fraction of regional blood flow rate,0.084706,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Fraction interstitial,0.73,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Volume of protein container,0.000457580178909003,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Volume,0.000457580178909003,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Start amount,1.78925582780515E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Volume of protein container,0.000405778649221191,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Volume,0.000405778649221191,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Start amount,1.58669856428004E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Volume of protein container,0.00484809188103879,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Volume,0.00484809188103879,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Relative expression out.,0,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Volume of protein container,0.00664122175484765,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Volume,0.000929771045678671,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Caecum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Weight (tissue),0.0121755737399095,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Volume,0.0121755737399095,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fluid recirculation flow rate,9.14390075072378E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Lymph flow rate,5.85885686226746E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Volume (endothelium),4.51105007063645E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Blood flow rate,0.03030195622839,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fraction intracellular,0.14,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fraction mucosa,0.19,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fraction of regional blood flow rate,0.15529,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fraction vascular,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Fraction interstitial,0.73,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Volume of protein container,0.000838897030679762,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Volume,0.000838897030679762,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Start amount,3.28030249179717E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Volume of protein container,0.000743927555508468,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Volume,0.000743927555508468,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Start amount,2.9089474927258E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Volume of protein container,0.0088881688301339,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Volume,0.0088881688301339,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Relative expression,0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Relative expression (normalized),0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Relative expression out.,0.0150931269808219,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Start amount,6.39383136233104E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Concentration,0.00719364301525618,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Volume of protein container,0.0121755737399095,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Volume,0.00170458032358732,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Relative expression,0.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Relative expression (normalized),0.397163120567376,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Relative expression out.,0.397163120567376,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Start amount,0.0068183212943493,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Concentration,4,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Relative expression,0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Relative expression (normalized),0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Relative expression out.,0.00010384615385,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Start amount,1.26438650380666E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Concentration,0.000741758241785714,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Weight (tissue),0.0277300144133263,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Volume,0.0277300144133263,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fluid recirculation flow rate,2.08253430210412E-06,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Lymph flow rate,0.00013343616383658,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Volume (endothelium),9.48366492935758E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Blood flow rate,0.062442050312865,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fraction intracellular,0.14,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fraction mucosa,0.21,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fraction of regional blood flow rate,0.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fraction vascular,0.12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Fraction interstitial,0.74,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Volume of protein container,0.00176362891668755,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Volume,0.00176362891668755,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Start amount,6.89624127686794E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Volume of protein container,0.0015639728129116,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Volume,0.0015639728129116,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Start amount,6.11553471722251E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Volume of protein container,0.0205202106658614,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Volume,0.0205202106658614,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Relative expression,0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Relative expression (normalized),0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Relative expression out.,0.0148891658054054,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Start amount,0.000145620271883086,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Concentration,0.00709643162315812,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Volume of protein container,0.0277300144133263,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Volume,0.00388220201786568,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Relative expression,0.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Relative expression (normalized),0.397163120567376,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Relative expression out.,0.397163120567376,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Start amount,0.0155288080714627,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Concentration,4,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Relative expression,0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Relative expression (normalized),0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Relative expression out.,0.00010384615385,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Start amount,2.879655343029E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Concentration,0.000741758241785714,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Weight (tissue),0.0138650072066631,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Volume,0.0138650072066631,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fluid recirculation flow rate,1.04126715105206E-06,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Lymph flow rate,6.671808191829E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Volume (endothelium),4.74183246467879E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Blood flow rate,0.0468315377346488,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fraction intracellular,0.14,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fraction mucosa,0.14,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fraction of regional blood flow rate,0.24,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fraction vascular,0.12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Fraction interstitial,0.74,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Volume of protein container,0.000881814458343775,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Volume,0.000881814458343775,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Start amount,3.44812063843397E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Volume of protein container,0.000781986406455801,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Volume,0.000781986406455801,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Start amount,3.05776735861126E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Volume of protein container,0.0102601053329307,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Volume,0.0102601053329307,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Relative expression,0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Relative expression (normalized),0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Relative expression out.,0.0148891658054054,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Start amount,7.28101359415428E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Concentration,0.00709643162315812,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Volume of protein container,0.0138650072066631,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Volume,0.00194110100893284,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Relative expression,0.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Relative expression (normalized),0.397163120567376,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Relative expression out.,0.397163120567376,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Start amount,0.00776440403573136,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Concentration,4,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Relative expression,0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Relative expression (normalized),0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Relative expression out.,0.00010384615385,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Start amount,1.4398276715145E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Concentration,0.000741758241785714,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Weight (tissue),0.0167122854723172,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Volume,0.0167122854723172,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fluid recirculation flow rate,1.25509879814311E-06,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Lymph flow rate,8.04191165979389E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Volume (endothelium),3.81040108768831E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Blood flow rate,0.0263427399757399,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fraction intracellular,0.14,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fraction mucosa,0.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fraction of regional blood flow rate,0.135,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fraction vascular,0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Fraction interstitial,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Volume of protein container,0.000708600904026248,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Volume,0.000708600904026248,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Start amount,2.77081122731301E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Volume of protein container,0.000628381933759125,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Volume,0.000628381933759125,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Start amount,2.45713448459833E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Volume of protein container,0.0130355826684074,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Volume,0.0130355826684074,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Relative expression,0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Relative expression (normalized),0.0786998764,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Relative expression out.,0.0141256188410256,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Start amount,8.77622174295382E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Concentration,0.00673251205273976,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Volume of protein container,0.0167122854723172,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Volume,0.0023397199661244,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Relative expression,0.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Relative expression (normalized),0.397163120567376,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Relative expression out.,0.397163120567376,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Start amount,0.00935887986449761,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Concentration,4,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Relative expression,0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Relative expression (normalized),0.00010384615385,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Relative expression out.,0.00010384615385,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Start amount,1.73550656834337E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Concentration,0.000741758241785714,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Weight (tissue),0.00680870889612922,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Volume,0.00680870889612922,V_GutWall*fractionMucosa,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fluid recirculation flow rate,5.11336547391635E-07,J_iso_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Lymph flow rate,3.27633437991603E-05,Q_lymph_intestine * V_seg / V_intestine,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Volume (endothelium),1.55238562831746E-05,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Blood flow rate,0.0107322273975237,Q * fractQ * regionalFractQ,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fraction intracellular,0.23,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fraction mucosa,0.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fraction of regional blood flow rate,0.055,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Hydraulic conductivity,1.86944444444444E-10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fraction vascular,0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (lipid),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (neutral lipid)-PT,0.0487,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (phospholipid)-PT,0.0163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (protein),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Fraction interstitial,0.69,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Albumin ratio (tissue/plasma),0.158,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Lipoprotein ratio (tissue/plasma),0.141,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (water),0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (neutral lipid)-RR,0.0375,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (neutral lipid)-WS,0.0483,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (neutral phospholipid)-RR,0.0124,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (neutral phospholipid, plasma)-WS,0.0182,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (extracellular water)-RR,0.282,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (protein)-WS,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (intracellular water)-RR,0.456,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (water)-WS,0.78,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Acidic phospholipids [mg/g] - RR,2.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Vf (acidic phospholipids)-WS,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Volume of protein container,0.000288689257195879,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Volume,0.000288689257195879,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Start amount,1.12884901853493E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Volume of protein container,0.000256007454494459,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Volume,0.000256007454494459,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Start amount,1.00105479002154E-08,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Volume of protein container,0.00469800913832916,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Volume,0.00469800913832916,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Relative expression out.,0,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|ATP1A2|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Volume of protein container,0.00680870889612922,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Volume,0.00156600304610972,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|pH,7.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|ABCB1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|CYP3A4|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|AADAC|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Degradation coefficient,0.000502280565623149,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|OATP1B1|t1/2,1380,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam|Partition coefficient (water/container),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Itraconazole|Partition coefficient (water/container),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|LargeIntestine|Mucosa|Rectum|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Weight (tissue),2.37703932874033,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fluid recirculation flow rate,7.07965356893528E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Lymph flow rate,0.00449767170376023,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Volume (endothelium),0.0115167555477469,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fraction intracellular,0.667,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Is liver zonated,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fraction of periportal zone,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Blood flow rate,0.426440855576015,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|EHC continuous fraction,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fluid recirculation flow proportionality factor,0.96,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Lymph flow proportionality factor,0.0199,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Organ volume mouse,0.0013,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Flow fraction via large pores,0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Hydraulic conductivity,3.88888888888889E-11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Radius (large pores),3.3E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Radius (small pores),9E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fraction vascular,0.17,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (lipid),0.069,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (neutral lipid)-PT,0.0348,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (phospholipid)-PT,0.0252,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (protein),0.184,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Microsomal protein mass/g tissue,0.04,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Number of cells/g tissue,139000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Albumin ratio (tissue/plasma),0.086,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Lipoprotein ratio (tissue/plasma),0.161,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (water),0.747,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (water)-PT,0.751,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Fraction interstitial,0.163,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (neutral lipid)-RR,0.0135,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (neutral lipid)-WS,0.0232,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (neutral phospholipid)-RR,0.0238,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (neutral phospholipid, plasma)-WS,0.0472,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (extracellular water)-RR,0.161,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (protein)-WS,0.21,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (intracellular water)-RR,0.481,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (water)-WS,0.68,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Acidic phospholipids [mg/g] - RR,4.56,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Vf (acidic phospholipids)-WS,0.0088,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Volume,2.37703932874033,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Specific blood flow rate,0.1794,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Volume|Percentile,0.513883032613831,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Volume|Mean,2.3578466712,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Volume|Deviation,0.551406891692952,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Specific blood flow rate|Mean,0.1794,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Specific blood flow rate|Deviation,0.00897,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Allometric scale factor,0.75,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Density (tissue),1,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Fraction of blood for sampling,1,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Weight (tissue),2.37703932874033,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Volume,2.37703932874033,V_liv * (IsLiverZonated ? f_periportal : 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Flow fraction via large pores,0.8,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Fluid recirculation flow rate,7.07965356893528E-05,J_iso * (IsLiverZonated?  f_periportal : 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Hydraulic conductivity,3.88888888888889E-11,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Lymph flow rate,0.00449767170376023,Q_lymph * (IsLiverZonated?  f_periportal : 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Radius (large pores),3.3E-07,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Radius (small pores),9E-08,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Volume (endothelium),0.0115167555477469,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (lipid),0.069,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (neutral lipid)-PT,0.0348,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (phospholipid)-PT,0.0252,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (protein),0.184,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Albumin ratio (tissue/plasma),0.086,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Albumin ratio (tissue/plasma)-PT,0.5,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Fraction vascular,0.17,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Lipoprotein ratio (tissue/plasma),0.161,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Microsomal protein mass/g tissue,0.04,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Number of cells/g tissue,139000,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (water),0.747,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (water)-PT,0.751,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Fraction intracellular,0.667,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Fraction interstitial,0.163,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (neutral lipid)-RR,0.0135,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (neutral lipid)-WS,0.0232,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (neutral phospholipid)-RR,0.0238,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (neutral phospholipid, plasma)-WS,0.0472,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (extracellular water)-RR,0.161,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (protein)-WS,0.21,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (intracellular water)-RR,0.481,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (water)-WS,0.68,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Acidic phospholipids [mg/g] - RR,4.56,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Vf (acidic phospholipids)-WS,0.0088,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Specific blood flow rate,0.1794,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Blood flow rate,0.426440855576015,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Volume of protein container,0.214171243519504,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Volume,0.214171243519504,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Start amount,8.37464477874061E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Volume of protein container,0.189925442366352,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Volume,0.189925442366352,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Start amount,7.42657178492092E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Volume of protein container,0.387457410584673,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Volume,0.387457410584673,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Start amount,0.387457410584673,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Concentration,1,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Relative expression,0.0223784807,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Relative expression (normalized),0.0223784807,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Relative expression out.,0.0915732921895706,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Start amount,0.0169107339096195,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Concentration,0.0436454006237775,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Volume of protein container,2.37703932874033,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Volume,1.5854852322698,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|pH,7.23,pH_cell_Liver,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Relative expression,0.2702702703,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Relative expression (normalized),0.191681042765957,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Relative expression out.,0.191681042765957,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Start amount,0.642443061892379,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Concentration,0.405202804047976,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Start amount,10.2688099001582,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Concentration,6.4767616191904,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Start amount,2.37703932874033,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Concentration,1.49925037481259,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam|Partition coefficient (water/container),0.031323460252418,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Itraconazole|Partition coefficient (water/container),0.00114975429900033,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.008955247411913,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00294814449875487,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000317409684171426,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Periportal|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Allometric scale factor,0.75,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Density (tissue),1,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Fraction of blood for sampling,1,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Weight (tissue),0,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Volume,0,V_liv * (IsLiverZonated ? 1 - f_periportal : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Flow fraction via large pores,0.8,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Hydraulic conductivity,3.88888888888889E-11,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Radius (large pores),3.3E-07,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Radius (small pores),9E-08,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Fluid recirculation flow rate,0,J_iso * (IsLiverZonated?  1-f_periportal : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Lymph flow rate,0,Q_lymph * (IsLiverZonated?  1-f_periportal : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Volume (endothelium),0,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (lipid),0.069,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (neutral lipid)-PT,0.0348,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Fraction vascular,0.17,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (phospholipid)-PT,0.0252,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (protein),0.184,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Albumin ratio (tissue/plasma),0.086,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Albumin ratio (tissue/plasma)-PT,0.5,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Lipoprotein ratio (tissue/plasma),0.161,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Microsomal protein mass/g tissue,0.04,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Number of cells/g tissue,139000,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (water),0.747,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (water)-PT,0.751,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Fraction intracellular,0.667,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Fraction interstitial,0.163,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (neutral lipid)-RR,0.0135,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (neutral lipid)-WS,0.0232,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (neutral phospholipid)-RR,0.0238,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (neutral phospholipid, plasma)-WS,0.0472,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (extracellular water)-RR,0.161,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (protein)-WS,0.21,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (intracellular water)-RR,0.481,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (water)-WS,0.68,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Acidic phospholipids [mg/g] - RR,4.56,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Vf (acidic phospholipids)-WS,0.0088,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Specific blood flow rate,0.1794,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Blood flow rate,0.426440855576015,Liver_Parameter,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Volume of protein container,0,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Volume,0,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Relative expression out.,NaN,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Start amount,NaN,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Volume of protein container,0,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Volume,0,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Volume of protein container,0,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Volume,0,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Relative expression,0.0223784807,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Relative expression (normalized),0.0223784807,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Relative expression out.,0.0915732921895706,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Volume of protein container,0,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Volume,0,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|pH,7.23,pH_cell_Liver,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Relative expression,0.2702702703,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Relative expression (normalized),0.191681042765957,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Relative expression out.,0.191681042765957,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Relative expression,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Relative expression (normalized),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Relative expression out.,1,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam|Partition coefficient (water/container),0.031323460252418,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Itraconazole|Partition coefficient (water/container),0.00114975429900033,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.008955247411913,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00294814449875487,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000317409684171426,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Pericentral|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Plasma|Volume,0.214171243519504,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|BloodCells|Volume,0.189925442366352,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Interstitial|Volume,0.387457410584673,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Intracellular|Volume,1.5854852322698,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Liver|Intracellular|pH,7.23,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Weight (tissue),1.21453864640878,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fluid recirculation flow rate,4.76374321372458E-08,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Lymph flow rate,0.0001149036206182,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Volume (endothelium),0.0200763238251371,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fraction intracellular,0.232,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Blood flow rate,6.08986753329448,Q_sto + Q_sin + Q_lin + Q_pan + Q_spl + Q_liv + Q_mus + Q_fat + Q_skn + Q_kid + Q_brn + Q_hrt + Q_bon + Q_tes,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fluid recirculation flow proportionality factor,0.01,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Lymph flow proportionality factor,3.56E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Organ volume mouse,0.0001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Hydraulic conductivity,5.66666666666667E-12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (lipid),0.01,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (neutral lipid)-PT,0.003,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (phospholipid)-PT,0.009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (protein),0.183,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Albumin ratio (tissue/plasma),0.212,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Lipoprotein ratio (tissue/plasma),0.168,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (water),0.807,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (water)-PT,0.811,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fraction interstitial,0.188,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (neutral lipid)-RR,0.0215,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (neutral lipid)-WS,0.0204,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (neutral phospholipid)-RR,0.0123,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (neutral phospholipid, plasma)-WS,0.0152,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (extracellular water)-RR,0.336,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (protein)-WS,0.11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (intracellular water)-RR,0.238,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (water)-WS,0.74,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Acidic phospholipids [mg/g] - RR,3.91,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Vf (acidic phospholipids)-WS,0.0044,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Volume,1.21453864640878,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fraction vascular,0.58,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Volume|Percentile,0.404165677440888,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Volume|Mean,1.2943497288,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Volume|GeometricDeviation,1.3,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fraction vascular|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Fraction vascular|Mean,0.58,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Volume of protein container,0.373349179906058,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Volume,0.373349179906058,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Start amount,1.45989102400791E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Volume of protein container,0.331083235011032,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Volume,0.331083235011032,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Start amount,1.29462034204475E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Volume of protein container,0.22833326552485,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Volume,0.22833326552485,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Relative expression,4.0079365079E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Relative expression (normalized),4.0079365079E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Relative expression out.,4.0079365079E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Start amount,9.15145230865071E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Concentration,4.0079365079E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Relative expression,0.0272345453,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Relative expression (normalized),0.0272345453,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Relative expression out.,0.0336085878170213,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Start amount,0.00365754020324111,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Concentration,0.0160184290047875,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Volume of protein container,1.21453864640878,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Volume,0.281772965966836,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|pH,6.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Relative expression,0.0927144536,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Relative expression (normalized),0.0657549316312057,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Relative expression out.,0.0657549316312057,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Start amount,0.112605286977873,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Concentration,0.399631265517241,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Relative expression,0.00042695753798,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Relative expression (normalized),0.00042695753798,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Relative expression out.,0.00042695753798,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Start amount,0.00224016377868973,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Concentration,0.00795024381066207,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Relative expression,0.0269230769,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Relative expression (normalized),0.0269230769,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Relative expression out.,0.0269230769,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Start amount,0.0326991173752854,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Concentration,0.116047745258621,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam|Partition coefficient (water/container),0.0223347512640929,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Itraconazole|Partition coefficient (water/container),0.000941892900056966,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00713722614766721,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00239414932205206,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.00026009181756677,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Lung|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Weight (tissue),32.6434194016053,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fluid recirculation flow rate,2.22935473881699E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Lymph flow rate,0.00118895843600085,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Volume (endothelium),0.0232584363236438,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fraction intracellular,0.815,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Blood flow rate,1.11607850934089,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fluid recirculation flow proportionality factor,0.292,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Lymph flow proportionality factor,0.00201,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Organ volume mouse,0.01,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Peripheral blood flow fraction,0.287,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Allometric scale factor,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Hydraulic conductivity,9E-12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Albumin ratio (tissue/plasma),0.064,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Lipoprotein ratio (tissue/plasma),0.059,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fraction vascular,0.025,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Acidic phospholipids [mg/g] - RR,2.42,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (acidic phospholipids)-WS,0.0009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Volume,32.6434194016053,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (lipid),0.013,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-PT,0.0238,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (phospholipid)-PT,0.0072,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (protein),0.177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water),0.811,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)-PT,0.76,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fraction interstitial,0.16,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-RR,0.022,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-WS,0.0049,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral phospholipid)-RR,0.0078,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral phospholipid, plasma)-WS,0.0042,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (extracellular water)-RR,0.079,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (protein)-WS,0.19,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (intracellular water)-RR,0.666,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)-WS,0.76,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Specific blood flow rate,0.03419,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Volume|Percentile,0.539200616049956,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Volume|Mean,32.338641984,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Volume|GeometricDeviation,1.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (lipid)|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (lipid)|Mean,0.013,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-PT|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-PT|Mean,0.0238,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (phospholipid)-PT|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (phospholipid)-PT|Mean,0.0072,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (protein)|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (protein)|Mean,0.177,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)|Mean,0.811,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)-PT|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)-PT|Mean,0.76,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fraction interstitial|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Fraction interstitial|Mean,0.16,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-RR|Mean,0.022,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral lipid)-WS|Mean,0.0049,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral phospholipid)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral phospholipid)-RR|Mean,0.0078,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral phospholipid, plasma)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (neutral phospholipid, plasma)-WS|Mean,0.0042,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (extracellular water)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (extracellular water)-RR|Mean,0.079,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (protein)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (protein)-WS|Mean,0.19,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (intracellular water)-RR|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (intracellular water)-RR|Mean,0.666,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)-WS|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Vf (water)-WS|Mean,0.76,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Specific blood flow rate|Mean,0.03419,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Specific blood flow rate|Deviation,0.0017095,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Volume of protein container,0.432525307071271,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Volume,0.432525307071271,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Start amount,1.69128485459241E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Volume of protein container,0.383560177968863,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Volume,0.383560177968863,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Start amount,1.49981864463855E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Volume of protein container,5.22294710425686,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Volume,5.22294710425686,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Relative expression,0.00064682539683,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Relative expression (normalized),0.00064682539683,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Relative expression out.,0.00064682539683,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Start amount,0.00337833483333304,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Concentration,0.00064682539683,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Relative expression,0.7034193524,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Relative expression (normalized),0.7034193524,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Relative expression out.,3.5830423262875,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Start amount,8.91943248121661,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Concentration,1.70773938605409,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Volume of protein container,32.6434194016053,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Volume,26.6043868123084,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|pH,6.81,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Relative expression,0.0180963572,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Relative expression (normalized),0.0128342958865248,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Relative expression out.,0.0128342958865248,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Start amount,0.590726977720861,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Concentration,0.0222041192638037,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Relative expression,0.00020833333333,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Relative expression (normalized),0.00020833333333,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Relative expression out.,0.00020833333333,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Start amount,0.00680071237522563,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Concentration,0.000255623721877301,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam|Partition coefficient (water/container),0.0281592452157211,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Itraconazole|Partition coefficient (water/container),0.000975144127315933,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00767798606812231,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.0025087802836828,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000269161142037067,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Muscle|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Weight (tissue),0.19044125208128,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Fluid recirculation flow rate,8.76768515988918E-07,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Lymph flow rate,0.00104563142536654,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Volume (endothelium),0.0010855151368633,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Fraction intracellular,0.68,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Blood flow rate,0.0651118640865896,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Fluid recirculation flow proportionality factor,0.01,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Lymph flow proportionality factor,0.0303,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Organ volume mouse,0.00013,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Hydraulic conductivity,3.22222222222222E-11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (lipid),0.08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (neutral lipid)-PT,0.0403,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (phospholipid)-PT,0.01067,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (protein),0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Albumin ratio (tissue/plasma),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Lipoprotein ratio (tissue/plasma),0.06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (water),0.71,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (water)-PT,0.71,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Fraction vascular,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Fraction interstitial,0.12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (neutral lipid)-RR,0.0403,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (neutral lipid)-WS,0.0403,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (neutral phospholipid)-RR,0.009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (neutral phospholipid, plasma)-WS,0.009,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (extracellular water)-RR,0.12,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (protein)-WS,0.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (intracellular water)-RR,0.521,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (water)-WS,0.71,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Acidic phospholipids [mg/g] - RR,1.67,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Vf (acidic phospholipids)-WS,0.00167,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Volume,0.19044125208128,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Specific blood flow rate,0.3419,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Volume|Percentile,0.501372414890296,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Volume|Mean,0.19026527664,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Volume|Deviation,0.051153121992552,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Specific blood flow rate|Mean,0.3419,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Specific blood flow rate|Deviation,0.017095,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Volume of protein container,0.0201867727206157,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Volume,0.0201867727206157,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Start amount,7.89354574340566E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Volume of protein container,0.0179014776956403,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Volume,0.0179014776956403,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Start amount,6.999936791322E-07,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Volume of protein container,0.0228529502497536,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Volume,0.0228529502497536,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Relative expression,0.0073903254795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Relative expression (normalized),0.0073903254795,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Relative expression out.,0.0418785110505,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Start amount,0.000456145256388115,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Concentration,0.0199600161643477,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Volume of protein container,0.19044125208128,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Volume,0.12950005141527,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|pH,7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Relative expression,0.0200940071,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Relative expression (normalized),0.0142510688652482,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Relative expression out.,0.0142510688652482,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Start amount,0.00382672787145413,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Concentration,0.0295500104411765,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Relative expression,0.1474358974,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Relative expression (normalized),0.1474358974,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Relative expression out.,0.1474358974,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Start amount,0.0280778769025831,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Concentration,0.216817496176471,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam|Partition coefficient (water/container),0.0169484303286013,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Itraconazole|Partition coefficient (water/container),0.000552248679484355,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00439743061108549,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00142540927408185,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000152373477240274,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Pancreas|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Weight (tissue),1.03741887696358,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Lymph flow rate,0.00552244340206265,Q_Lymph_sto + Q_Lymph_sin_incl_Mucosa + Q_Lymph_lin_incl_Mucosa + Q_Lymph_pan + Q_Lymph_spl,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Blood flow rate,1.20652821277344,Q_sto + Q_sin + Q_lin + Q_pan + Q_spl,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Fraction vascular,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Volume,1.03741887696358,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Volume|Percentile,0.501500784871721,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Volume|Mean,1.0372237776,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Volume|Deviation,0.05186118888,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Volume of protein container,0.549832004790699,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Volume,0.549832004790699,(1-HCT)*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Start amount,2.14998412132093E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Volume of protein container,0.487586872172884,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Volume,0.487586872172884,HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Start amount,1.90658969249215E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|PortalVein|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Weight (tissue),3.76304528677595,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Fluid recirculation flow rate,3.26930653868491E-05,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Lymph flow rate,0.000606908158461946,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Volume (endothelium),0.00493335237096327,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Fraction intracellular,0.652,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Blood flow rate,0.325315265041781,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Fluid recirculation flow proportionality factor,0.617,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Lymph flow proportionality factor,0.00352,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Organ volume mouse,0.0029,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Peripheral blood flow fraction,0.713,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Allometric scale factor,1.6,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Fraction vascular,0.046,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Flow fraction via large pores,0.05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Hydraulic conductivity,1.94722E-11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Radius (large pores),2.5E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Radius (small pores),4.5E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (lipid),0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (neutral lipid)-PT,0.0284,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (phospholipid)-PT,0.0111,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (protein),0.288,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Albumin ratio (tissue/plasma),0.277,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Lipoprotein ratio (tissue/plasma),0.096,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (water),0.612,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (water)-PT,0.718,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Fraction interstitial,0.302,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (neutral lipid)-RR,0.0603,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (neutral lipid)-WS,0.126,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (neutral phospholipid)-RR,0.0044,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (neutral phospholipid, plasma)-WS,0.0112,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (extracellular water)-RR,0.382,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (protein)-WS,0.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (intracellular water)-RR,0.276,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (water)-WS,0.47,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Acidic phospholipids [mg/g] - RR,1.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Vf (acidic phospholipids)-WS,0.0028,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Volume,3.76304528677595,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Specific blood flow rate,0.08645,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Volume|Percentile,0.504523716285438,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Volume|Mean,3.760912944,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Volume|Deviation,0.1880456472,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Specific blood flow rate|Mean,0.08645,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Specific blood flow rate|Deviation,0.0043225,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Volume of protein container,0.0917430440915977,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Volume,0.0917430440915977,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Start amount,3.58738826259605E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Volume of protein container,0.081357039100096,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Volume,0.081357039100096,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Start amount,3.18126883664178E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Volume of protein container,1.13643967660634,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Volume,1.13643967660634,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Relative expression,0.0389467988,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Relative expression (normalized),0.0389467988,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Relative expression out.,0.0840838172768212,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Start amount,0.0455437161349133,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Concentration,0.0400757885107611,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Volume of protein container,3.76304528677595,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Volume,2.45350552697792,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam|Partition coefficient (water/container),0.0105195707007435,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Itraconazole|Partition coefficient (water/container),0.000385299004092396,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.00300447916565448,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.000988046754583595,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000106333093307126,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Skin|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Weight (tissue),0.206952423181902,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Fluid recirculation flow rate,2.75134378975835E-07,f_Jiso * (1-alpha_l) * Q_lymph * (V/V_mouse)^(exp_Jiso_scale - 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Lymph flow rate,0.00174863733394783,f_lymph*Q*(1-HCT),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Volume (endothelium),0.00194638754002579,SA_pls_int*d_endo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Fraction intracellular,0.52,1 - f_int - f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Blood flow rate,0.165794760021601,Qspec * Weight,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Fluid recirculation flow proportionality factor,0.01,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Lymph flow proportionality factor,0.0199,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Organ volume mouse,0.0001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Allometric scale factor,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Fraction of blood for sampling,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Flow fraction via large pores,0.8,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Hydraulic conductivity,3.88888888888889E-11,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Radius (large pores),3.3E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Radius (small pores),9E-08,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (lipid),0.016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (neutral lipid)-PT,0.0201,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Fraction vascular,0.33,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (phospholipid)-PT,0.0198,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (protein),0.194,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Albumin ratio (tissue/plasma),0.097,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Albumin ratio (tissue/plasma)-PT,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Lipoprotein ratio (tissue/plasma),0.207,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (water),0.778,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (water)-PT,0.788,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Fraction interstitial,0.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (neutral lipid)-RR,0.0071,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (neutral lipid)-WS,0.006,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (neutral phospholipid)-RR,0.0107,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (neutral phospholipid, plasma)-WS,0.0108,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (extracellular water)-RR,0.207,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (protein)-WS,0.23,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (intracellular water)-RR,0.355,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (water)-WS,0.75,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Acidic phospholipids [mg/g] - RR,3.18,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Vf (acidic phospholipids)-WS,0.003,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Volume,0.206952423181902,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Specific blood flow rate,0.801125,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Volume|Percentile,0.344505829337596,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Volume|Mean,0.24341181216,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Volume|GeometricDeviation,1.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Specific blood flow rate|Percentile,0.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Specific blood flow rate|Mean,0.801125,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Specific blood flow rate|Deviation,0.04005625,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Volume of protein container,0.0361959788145147,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Volume,0.0361959788145147,f_vas*(1-HCT)*V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Relative expression,3.9102564103E-05,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Start amount,1.41535558186539E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Relative expression,0,rel_exp_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Relative expression (normalized),0,rel_exp_pls_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Relative expression out.,0,rel_exp_norm + HCT / (1-HCT) * rel_exp_bc_norm + V_vasend/V_pls * rel_exp_vendo_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam|Partition coefficient (water/container),0.016,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Itraconazole|Partition coefficient (water/container),0.006016197247,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Hydroxy-Itraconazole|Partition coefficient (water/container),0.017,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Keto-Itraconazole|Partition coefficient (water/container),0.01,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.011,fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Plasma|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Volume of protein container,0.032098320835513,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Volume,0.032098320835513,f_vas*HCT*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Relative expression,0,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Relative expression (normalized),0,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Relative expression,3.9102564103E-05,rel_exp_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Relative expression (normalized),3.9102564103E-05,rel_exp_bc_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Relative expression out.,3.9102564103E-05,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Start amount,1.25512664806931E-06,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Concentration,3.9102564103E-05,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam|Partition coefficient (water/container),17.0986813978402,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Itraconazole|Partition coefficient (water/container),513.145430016521,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Hydroxy-Itraconazole|Partition coefficient (water/container),64.2413700013706,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Keto-Itraconazole|Partition coefficient (water/container),198.513483542922,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole|Partition coefficient (water/container),1859.12209436522,K_rbc/fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|BloodCells|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Volume of protein container,0.0310428634772853,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Volume,0.0310428634772853,f_int*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|pH,7.4,pH_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|OATP1B1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Relative expression,0.0103243118,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Relative expression (normalized),0.0103243118,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Relative expression out.,0.0357909475733333,f_cell/f_int * rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Start amount,0.000529547141195553,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Concentration,0.0170585790702921,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|ATP1A2|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Midazolam|Partition coefficient (water/container),0.042163173166682,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Itraconazole|Partition coefficient (water/container),0.0161048689416368,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0447285484907193,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|Keto-Itraconazole|Partition coefficient (water/container),0.0266011356556834,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Interstitial|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.0292152119465357,K_water_int,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Volume of protein container,0.206952423181902,Volume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Volume,0.107615260054589,f_cell*V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Relative expression,0.1047003525,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Relative expression (normalized),0.0742555691489362,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Relative expression out.,0.0742555691489362,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Start amount,0.0216679916578743,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Concentration,0.201346831730769,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|ABCB1|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Relative expression,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Relative expression (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Relative expression out.,0,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Start amount,0,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|CYP3A4|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Degradation coefficient,0.000320901472481456,ln(2)/tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Relative expression,0.00037115384615,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Relative expression (normalized),0.00037115384615,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Relative expression out.,0.00037115384615,rel_exp_norm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Start amount,7.68111878340253E-05,rel_exp_out * AF * f_onto * ProteinContainerVolume,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Concentration,0.000713757396442308,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|Ontogeny factor,1,f_onto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|AADAC|t1/2,2160,tHalf,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam|Partition coefficient (water/container),0.0519321019880995,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Itraconazole|Partition coefficient (water/container),0.00229931916284881,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Hydroxy-Itraconazole|Partition coefficient (water/container),0.0172224261211321,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Keto-Itraconazole|Partition coefficient (water/container),0.00582542670572843,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole|Partition coefficient (water/container),0.000635338013471513,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam-CYP3A4-Patki et al. Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam-CYP3A4-Patki et al.|kcat_app,13,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam-CYP3A4-Patki et al.|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3 + K_water4*Ic4/KcI4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Midazolam-CYP3A4-Patki et al.|Km_app,2.73,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0402937875,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0020688492598,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0203370845,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0041716224833,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.3933927416,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0022214874285,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat interaction factor,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat_app,0.0605873508,kcat * kcat_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km interaction factor,1,1 + K_water1*Ic1/KcI1 + K_water2*Ic2/KcI2 + K_water3*Ic3/KcI3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Spleen|Intracellular|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km_app,0.0006284266369,Km * Km_interaction_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Weight (tissue),0.00600000003653008,Volume * Density,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Volume,0.00600000003653008,0.006 * BW / 73,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Density (tissue),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva flow rate,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|Volume,0.00600000003653008,V_slv,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|pH (saliva),7.4,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|Saliva|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|SalivaGland|Volume,0.00600000003653008,V_slv,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|SalivaGland|Midazolam|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|SalivaGland|Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|SalivaGland|Hydroxy-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|SalivaGland|Keto-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Organism|Saliva|SalivaGland|N-desalkyl-Itraconazole|Concentration,0,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|VenousBlood_pls_VenousBlood_bc|Surface area (blood cells/plasma),45399.1838671772,HCT * A_to_V_bc * 0.6 * V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ArterialBlood_pls_ArterialBlood_bc|Surface area (blood cells/plasma),19737.3889675118,HCT * A_to_V_bc * 0.6 * V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Surface area (interstitial/intracellular),92629.4626563408,(V_bon * 1000 / 28.2)^0.75 * 10 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|P*SA interstitial -> intracellular,300.848795898934,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|P*SA intracellular -> interstitial,300.848795898934,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|Partition coefficient (intracellular/plasma),0.463033963914266,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|Partition coefficient (intracellular/water),0.0345547006201094,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|P*SA interstitial -> intracellular,90.9100648313165,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|P*SA intracellular -> interstitial,90.9100648313165,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|Partition coefficient (intracellular/plasma),4.53258427947183,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|Partition coefficient (intracellular/water),0.00132732165053113,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,9.85663521179258,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,9.85663521179258,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),1.65828774198745,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.0102515381194494,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,31.1971515715682,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,31.1971515715682,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),2.94623771846742,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00339415924835889,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,541.982337707893,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,541.982337707893,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),30.0196809544672,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000366426279369338,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_int_Bone_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_bc|Surface area (blood cells/plasma),18924.5603020381,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Surface area (plasma/interstitial),3817.54199833018,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Bone_pls_Bone_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Surface area (interstitial/intracellular),9.8844643476918,(V_brn  * 1000 / 1.671)^0.75 * 0.0006 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|P*SA interstitial -> intracellular,0.0321034918246442,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|P*SA intracellular -> interstitial,0.0321034918246442,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|Partition coefficient (intracellular/plasma),0.864475940107906,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|Partition coefficient (intracellular/water),0.0185083230864735,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|P*SA interstitial -> intracellular,0.0097009878812029,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|P*SA intracellular -> interstitial,0.0097009878812029,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.0207282569583,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|Partition coefficient (intracellular/water),0.000600375251451651,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00105179881805671,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00105179881805671,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.55380048989519,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00478361124895375,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00332903941808189,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00332903941808189,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.45160030170077,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.0015500030275223,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.057834785396821,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.057834785396821,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),66.400715032311,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000165660866673609,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_int_Brain_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_bc|Surface area (blood cells/plasma),2771.67617219849,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Surface area (plasma/interstitial),559.114189405989,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Midazolam|P (plasma<->interstitial),0.00162393685157764,P/2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Itraconazole|P (plasma<->interstitial),0.000490718947429268,P/2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Hydroxy-Itraconazole|P (plasma<->interstitial),5.32046442305355E-05,P/2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Keto-Itraconazole|P (plasma<->interstitial),0.00016839756313448,P/2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),0.00292553968340867,P/2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Brain_pls_Brain_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Surface area (interstitial/intracellular),91037.2140687979,(V_fat * 1000 / 14.2)^0.75 * 5 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|P*SA interstitial -> intracellular,295.677373582567,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|P*SA intracellular -> interstitial,295.677373582567,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|Partition coefficient (intracellular/plasma),1.83115742395628,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP_ow*f_nl+(0.3*10^LogP_ow+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|Partition coefficient (intracellular/water),0.0087376430833737,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|P*SA interstitial -> intracellular,89.347371729467,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|P*SA intracellular -> interstitial,89.347371729467,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|Partition coefficient (intracellular/plasma),32.8486486109534,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP_ow*f_nl+(0.3*10^LogP_ow+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|Partition coefficient (intracellular/water),0.00018314900312197,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,9.68720517253899,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,9.68720517253899,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),9.08955577342994,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP_ow*f_nl+(0.3*10^LogP_ow+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00187027841885226,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,30.6608900074752,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,30.6608900074752,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),18.9111132782399,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP_ow*f_nl+(0.3*10^LogP_ow+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.000528789598627518,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,532.665964850476,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,532.665964850476,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),252.522319113164,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP_ow*f_nl+(0.3*10^LogP_ow+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),4.35605060124231E-05,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_int_Fat_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_bc|Surface area (blood cells/plasma),12422.0050577965,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Surface area (plasma/interstitial),2505.81917121219,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Fat_pls_Fat_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Surface area (interstitial/intracellular),1608.0649463929,(V_tes * 1000 / 2.5)^0.75 * 2 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|P*SA interstitial -> intracellular,5.22279185235532,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|P*SA intracellular -> interstitial,5.22279185235532,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|Partition coefficient (intracellular/plasma),0.227622253184519,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|Partition coefficient (intracellular/water),0.0702918971065179,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|P*SA interstitial -> intracellular,1.57821587578366,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|P*SA intracellular -> interstitial,1.57821587578366,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|Partition coefficient (intracellular/plasma),2.10308190263042,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|Partition coefficient (intracellular/water),0.00286065760894775,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.171113046744859,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.171113046744859,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),0.780489369401661,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.0217812063385726,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.541588436669086,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.541588436669086,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),1.371733909165,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00729004359605516,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,9.40891562834173,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,9.40891562834173,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),13.9091510332286,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.00079084625465072,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_int_Gonads_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_bc|Surface area (blood cells/plasma),104.303703729685,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Surface area (plasma/interstitial),21.0405823551197,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Gonads_pls_Gonads_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Surface area (interstitial/intracellular),60754.2461403441,(V_hrt * 1000 / 1.2)^0.75 * 7.54 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|P*SA interstitial -> intracellular,197.322118394247,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|P*SA intracellular -> interstitial,197.322118394247,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|Partition coefficient (intracellular/plasma),0.492561090230238,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|Partition coefficient (intracellular/water),0.0324832803835989,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|P*SA interstitial -> intracellular,59.6265194356967,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|P*SA intracellular -> interstitial,59.6265194356967,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|Partition coefficient (intracellular/plasma),4.23103609371122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|Partition coefficient (intracellular/water),0.00142192056833128,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,6.46481610278279,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,6.46481610278279,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),1.59111426073935,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.0106843363920958,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,20.4617340002127,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,20.4617340002127,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),2.7737809401466,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00360518736547071,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,355.477916038309,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,355.477916038309,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),28.0069762044226,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000392759286818795,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_int_Heart_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_bc|Surface area (blood cells/plasma),2753.4799293897,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Surface area (plasma/interstitial),555.443566679453,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Heart_pls_Heart_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Surface area (interstitial/intracellular),2226341.0811827,(V_kid * 1000 / 7)^0.75 * 1000 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|P*SA interstitial -> intracellular,7230.87465182761,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|P*SA intracellular -> interstitial,7230.87465182761,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|Partition coefficient (intracellular/plasma),0.523645232149911,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|Partition coefficient (intracellular/water),0.0305550380632884,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|P*SA interstitial -> intracellular,2185.01550395303,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|P*SA intracellular -> interstitial,2185.01550395303,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|Partition coefficient (intracellular/plasma),4.89451553986034,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|Partition coefficient (intracellular/water),0.00122917114022927,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,236.903370320303,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,236.903370320303,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),1.80820817291407,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00940157237128465,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,749.820825554702,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,749.820825554702,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),3.190707717919,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00313410092182372,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,13026.4983636059,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,13026.4983636059,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),32.4064064750267,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000339439055313859,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_int_Kidney_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_cell_Kidney_ur|Midazolam|Partition coefficient (intracellular/water),0.0305550380632884,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_cell_Kidney_ur|Itraconazole|Partition coefficient (intracellular/water),0.00122917114022927,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_cell_Kidney_ur|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00940157237128465,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_cell_Kidney_ur|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00313410092182372,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_cell_Kidney_ur|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000339439055313859,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_bc|Surface area (blood cells/plasma),4748.7618358491,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Surface area (plasma/interstitial),957.940235286161,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_ur|Midazolam|Glomerular Filtration-GFR|GFR fraction,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_ur|Itraconazole|Glomerular Filtration-GFR|GFR fraction,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_ur|Hydroxy-Itraconazole|Glomerular Filtration-GFR|GFR fraction,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_ur|Keto-Itraconazole|Glomerular Filtration-GFR|GFR fraction,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Kidney_pls_Kidney_ur|N-desalkyl-Itraconazole|Glomerular Filtration-GFR|GFR fraction,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Midazolam|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Hydroxy-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|Keto-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_pls|N-desalkyl-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_F1,0.557311633762293,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K1,0.557311633762293,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K2,0.442688366237707,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.99718953802679,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.99718953802679,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00281046197321022,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.99718953802679,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.99718953802679,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00281046197321022,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.99718953802679,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.99718953802679,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00281046197321022,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.99822487725419,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999980501934184,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.998205413799835,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00177508813434969,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,1.94634543554534E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46114601285363E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uje_UpperJejunum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Midazolam|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Hydroxy-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|Keto-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_pls|N-desalkyl-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_F1,0.853883683643945,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K1,0.853883683643945,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K2,0.146116316356055,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.999393212821241,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.999393212821241,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.000606787178759394,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.999393212821241,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.999393212821241,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.000606787178759394,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.999393212821241,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.999393212821241,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.000606787178759394,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999617057420559,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999909497475545,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999526589553374,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000382907922170998,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,9.04678671843671E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46572701605534E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lje_LowerJejunum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_sto_Lumen_duo|Midazolam|Oral mass absorbed,0,MAbs_duo + MAbs_uje + MAbs_lje + MAbs_uil + MAbs_lil + MAbs_cae + MAbs_colasc + MAbs_coltrans + MAbs_coldesc + MAbs_colsigm + MAbs_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_sto_Lumen_duo|Itraconazole|Oral mass absorbed,0,MAbs_duo + MAbs_uje + MAbs_lje + MAbs_uil + MAbs_lil + MAbs_cae + MAbs_colasc + MAbs_coltrans + MAbs_coldesc + MAbs_colsigm + MAbs_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_sto_Lumen_duo|Hydroxy-Itraconazole|Oral mass absorbed,0,MAbs_duo + MAbs_uje + MAbs_lje + MAbs_uil + MAbs_lil + MAbs_cae + MAbs_colasc + MAbs_coltrans + MAbs_coldesc + MAbs_colsigm + MAbs_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_sto_Lumen_duo|Keto-Itraconazole|Oral mass absorbed,0,MAbs_duo + MAbs_uje + MAbs_lje + MAbs_uil + MAbs_lil + MAbs_cae + MAbs_colasc + MAbs_coltrans + MAbs_coldesc + MAbs_colsigm + MAbs_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_sto_Lumen_duo|N-desalkyl-Itraconazole|Oral mass absorbed,0,MAbs_duo + MAbs_uje + MAbs_lje + MAbs_uil + MAbs_lil + MAbs_cae + MAbs_colasc + MAbs_coltrans + MAbs_coldesc + MAbs_colsigm + MAbs_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Surface area (interstitial/intracellular),4354539.30787913,(V_sto * 1000 / 1.1)^0.75 * 1000 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|P*SA interstitial -> intracellular,14142.9937074166,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|P*SA intracellular -> interstitial,14142.9937074166,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|P*SA interstitial -> intracellular,4273.70989140364,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|P*SA intracellular -> interstitial,4273.70989140364,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,463.363429327183,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,463.363429327183,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,1466.5876160403,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,1466.5876160403,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,25478.7550963266,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,25478.7550963266,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_int_Stomach_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_bc|Surface area (blood cells/plasma),253.95953892049,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Surface area (plasma/interstitial),51.229787653303,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Stomach_pls_Stomach_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Midazolam|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Hydroxy-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|Keto-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_pls|N-desalkyl-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_F1,0.91959269389056,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K1,0.91959269389056,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K2,0.0804073061094398,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.999689854642498,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.999689854642498,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.000310145357502178,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.999689854642498,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.999689854642498,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.000310145357502178,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.999689854642498,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.999689854642498,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.000310145357502178,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999804289108372,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.99982289815775,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999627221926881,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000195676230868387,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,0.000177067181490827,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46607594557363E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_uil_UpperIleum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Surface area (interstitial/intracellular),1946913.483626,((V_sin-V_Mucosa) * 1000 / 11.1)^0.75 * 1000 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|P*SA interstitial -> intracellular,6323.32910578732,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|P*SA intracellular -> interstitial,6323.32910578732,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|P*SA interstitial -> intracellular,1910.7746708416,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|P*SA intracellular -> interstitial,1910.7746708416,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,207.169678487907,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,207.169678487907,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,655.710972552559,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,655.710972552559,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,11391.5453130225,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,11391.5453130225,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_int_SmallIntestine_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_bc|Surface area (blood cells/plasma),657.095768532853,HCT * A_to_V_bc * 0.6 * (V-V_Mucosa) * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Surface area (plasma/interstitial),132.552125558715,k * f_vas_org * (V_org-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_SmallIntestine_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_Duodenum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_Duodenum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_Duodenum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_Duodenum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_Duodenum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_Duodenum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_Duodenum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_Duodenum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_Duodenum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_Duodenum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperJejunum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperJejunum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperJejunum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperJejunum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperJejunum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperJejunum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperJejunum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperJejunum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperJejunum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperJejunum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerJejunum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerJejunum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerJejunum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerJejunum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerJejunum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerJejunum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerJejunum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerJejunum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerJejunum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerJejunum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperIleum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperIleum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperIleum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperIleum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_UpperIleum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperIleum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperIleum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperIleum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperIleum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_UpperIleum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Midazolam|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Hydroxy-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|Keto-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_pls|N-desalkyl-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_F1,0.953134403840196,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K1,0.953134403840196,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K2,0.0468655961598043,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.999825568771748,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.999825568771748,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.000174431228251781,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.999825568771748,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.999825568771748,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.000174431228251781,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.999825568771748,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.999825568771748,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.000174431228251781,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999889934250213,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999685106843655,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.99957507575282,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000110031090835203,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,0.000314858497393342,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46589513557352E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_lil_LowerIleum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerIleum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerIleum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerIleum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerIleum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_pls_LowerIleum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerIleum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerIleum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerIleum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerIleum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|SmallIntestine_bc_LowerIleum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Surface area (interstitial/intracellular),1269473.41132386,((V_lin-V_Mucosa) * 1000 / 11.1)^0.75 * 1000 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|P*SA interstitial -> intracellular,4123.08930949361,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|P*SA intracellular -> interstitial,4123.08930949361,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|P*SA interstitial -> intracellular,1245.90931238858,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|P*SA intracellular -> interstitial,1245.90931238858,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,135.083762419221,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,135.083762419221,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,427.552457861908,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,427.552457861908,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,7427.78968372027,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,7427.78968372027,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_int_LargeIntestine_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_bc|Surface area (blood cells/plasma),371.533471503248,HCT * A_to_V_bc * 0.6 * (V-V_Mucosa) * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Surface area (plasma/interstitial),74.9472964556176,k * f_vas_org * (V_org-V_Mucosa),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_LargeIntestine_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Caecum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Caecum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Caecum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Caecum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Caecum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Caecum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Caecum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Caecum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Caecum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Caecum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonAscendens_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonAscendens_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonAscendens_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonAscendens_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonAscendens_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonAscendens_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonAscendens_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonAscendens_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonAscendens_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonAscendens_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonTransversum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonTransversum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonTransversum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonTransversum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonTransversum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonTransversum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonTransversum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonTransversum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonTransversum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonTransversum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonDescendens_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonDescendens_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonDescendens_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonDescendens_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonDescendens_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonDescendens_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonDescendens_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonDescendens_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonDescendens_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonDescendens_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonSigmoid_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonSigmoid_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonSigmoid_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonSigmoid_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_ColonSigmoid_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonSigmoid_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonSigmoid_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonSigmoid_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonSigmoid_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_ColonSigmoid_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Rectum_pls|Midazolam|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Rectum_pls|Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Rectum_pls|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Rectum_pls|Keto-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_pls_Rectum_pls|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Rectum_bc|Midazolam|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Rectum_bc|Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Rectum_bc|Hydroxy-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Rectum_bc|Keto-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LargeIntestine_bc_Rectum_bc|N-desalkyl-Itraconazole|Mass transfer rate (intestine to mucosa blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Liver_int_Liver_cell|Surface area (interstitial/intracellular),496410.692950469,(V_liv * 1000 / 10)^0.75 * 82 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Liver_pls_Liver_bc|Surface area (blood cells/plasma),19030.5293251085,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Liver_pls_Liver_int|Surface area (plasma/interstitial),3838.91851591563,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Surface area (interstitial/intracellular),496410.692950469,SA_int_cell * (IsLiverZonated?  f_periportal : 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|P*SA interstitial -> intracellular,1612.27923559892,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|P*SA intracellular -> interstitial,1612.27923559892,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|Partition coefficient (intracellular/plasma),0.510799249861448,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|Partition coefficient (intracellular/water),0.031323460252418,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|P*SA interstitial -> intracellular,487.196265474576,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|P*SA intracellular -> interstitial,487.196265474576,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|Partition coefficient (intracellular/plasma),5.23259382655133,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|Partition coefficient (intracellular/water),0.00114975429900033,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,52.8227086213266,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,52.8227086213266,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),1.898328345165,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.008955247411913,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,167.188702013515,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,167.188702013515,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),3.39196399776993,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00294814449875487,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,2904.53836298998,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,2904.53836298998,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),34.6555273784878,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000317409684171426,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_int_Periportal_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_bc|Surface area (blood cells/plasma),19030.5293251085,SA_pls_bc * (IsLiverZonated?  f_periportal : 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Surface area (plasma/interstitial),3838.91851591563,SA_pls_int * (IsLiverZonated?  f_periportal : 1),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Periportal_pls_Periportal_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Surface area (interstitial/intracellular),0,SA_int_cell * (IsLiverZonated?  1-f_periportal : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|P*SA interstitial -> intracellular,0,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|P*SA intracellular -> interstitial,0,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|Partition coefficient (intracellular/plasma),0.510799249861448,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|Partition coefficient (intracellular/water),0.031323460252418,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|P*SA interstitial -> intracellular,0,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|P*SA intracellular -> interstitial,0,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|Partition coefficient (intracellular/plasma),5.23259382655133,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|Partition coefficient (intracellular/water),0.00114975429900033,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),1.898328345165,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.008955247411913,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),3.39196399776993,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00294814449875487,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),34.6555273784878,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000317409684171426,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_int_Pericentral_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_bc|Surface area (blood cells/plasma),0,SA_pls_bc * (IsLiverZonated?  1-f_periportal : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Surface area (plasma/interstitial),0,SA_pls_int * (IsLiverZonated?  1-f_periportal : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pericentral_pls_Pericentral_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Surface area (interstitial/intracellular),1093.35885429615,(V_lng * 1000  / 2.2)^0.75 * 0.096 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|P*SA interstitial -> intracellular,3.55109147098044,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|P*SA intracellular -> interstitial,3.55109147098044,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|Partition coefficient (intracellular/plasma),0.716372428365605,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|Partition coefficient (intracellular/water),0.0223347512640929,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|P*SA interstitial -> intracellular,1.07306381228535,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|P*SA intracellular -> interstitial,1.07306381228535,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|Partition coefficient (intracellular/plasma),6.38734748572384,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|Partition coefficient (intracellular/water),0.000941892900056966,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.116343537718265,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.116343537718265,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),2.38187772788402,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00713722614766721,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.368237933389956,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.368237933389956,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),4.17684891576807,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00239414932205206,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,6.39732943289922,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,6.39732943289922,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),42.292756853745,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.00026009181756677,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_int_Lung_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_bc|Surface area (blood cells/plasma),33174.5401481055,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Surface area (plasma/interstitial),6692.10794171236,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lung_pls_Lung_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Surface area (interstitial/intracellular),53873.797593866,(V_mus * 1000 / 110.1)^0.75 * 7.54 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|P*SA interstitial -> intracellular,174.975290494228,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|P*SA intracellular -> interstitial,174.975290494228,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|Partition coefficient (intracellular/plasma),0.568197047805361,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|Partition coefficient (intracellular/water),0.0281592452157211,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|P*SA interstitial -> intracellular,52.8737864985587,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|P*SA intracellular -> interstitial,52.8737864985587,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|Partition coefficient (intracellular/plasma),6.16954671465794,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|Partition coefficient (intracellular/water),0.000975144127315933,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,5.73267246865904,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,5.73267246865904,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),2.21412227753071,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00767798606812231,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,18.1444324632145,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,18.1444324632145,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),3.98600071319133,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.0025087802836828,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,315.219865513562,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,315.219865513562,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),40.8677118723368,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000269161142037067,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_int_Muscle_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_bc|Surface area (blood cells/plasma),38432.7298324801,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Surface area (plasma/interstitial),7752.81210788127,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Muscle_pls_Muscle_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Surface area (interstitial/intracellular),4210786.83914732,(V_pan * 1000 / 1.3)^0.75 * 1000 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|P*SA interstitial -> intracellular,13676.103844459,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|P*SA intracellular -> interstitial,13676.103844459,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|Partition coefficient (intracellular/plasma),0.94404022613228,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|Partition coefficient (intracellular/water),0.0169484303286013,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|P*SA interstitial -> intracellular,4132.62577111078,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|P*SA intracellular -> interstitial,4132.62577111078,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.8940002402857,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|Partition coefficient (intracellular/water),0.000552248679484355,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,448.066831414909,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,448.066831414909,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.86589386018842,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00439743061108549,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,1418.1724851823,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,1418.1724851823,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),7.01552893041284,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00142540927408185,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,24637.6479926009,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,24637.6479926009,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),72.191041375622,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000152373477240274,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_int_Pancreas_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_bc|Surface area (blood cells/plasma),1793.72806510316,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Surface area (plasma/interstitial),361.838378954432,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Pancreas_pls_Pancreas_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Midazolam|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|Keto-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_F1,0.738109032540418,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K1,0.738109032540418,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K2,0.261890967459582,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999206302221831,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999956350322153,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999162687188637,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000793663133516853,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.3615033194211E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46446523245957E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_rect_Rectum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|PortalVein_pls_PortalVein_bc|Surface area (blood cells/plasma),48856.204591723,HCT * A_to_V_bc * 0.6 * V,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Surface area (interstitial/intracellular),340.971855236478,(V_skn * 1000 / 43.4)^0.75 * 0.12 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|P*SA interstitial -> intracellular,1.10743352213863,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|P*SA intracellular -> interstitial,1.10743352213863,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|Partition coefficient (intracellular/plasma),1.52097461532999,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|Partition coefficient (intracellular/water),0.0105195707007435,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|P*SA interstitial -> intracellular,0.334642699809298,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|P*SA intracellular -> interstitial,0.334642699809298,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|Partition coefficient (intracellular/plasma),15.6143597131056,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|Partition coefficient (intracellular/water),0.000385299004092396,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.0362825725009649,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.0362825725009649,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),5.65821863380997,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00300447916565448,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.114837659038531,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.114837659038531,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),10.1209785403469,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.000988046754583595,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,1.99505338683958,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,1.99505338683958,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),103.448509376364,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000106333093307126,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_int_Skin_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_bc|Surface area (blood cells/plasma),8151.97531782962,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Surface area (plasma/interstitial),1644.45079032109,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Skin_pls_Skin_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Surface area (interstitial/intracellular),4481726.73468187,(V_spl * 1000 / 1.3)^0.75 * 1000 * 1E2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|P (interstitial->intracellular),0.00324787370315529,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|P (intracellular->interstitial),0.00324787370315529,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|P*SA interstitial -> intracellular,14556.0824063013,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|P*SA intracellular -> interstitial,14556.0824063013,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|Partition coefficient (intracellular/plasma),0.308094596357114,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|Partition coefficient (intracellular/water),0.0519321019880995,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|P (interstitial->intracellular),0.000981437894858537,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|P (intracellular->interstitial),0.000981437894858537,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|P*SA interstitial -> intracellular,4398.5364518174,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|P*SA intracellular -> interstitial,4398.5364518174,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|Partition coefficient (intracellular/plasma),2.61651246343115,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|Partition coefficient (intracellular/water),0.00229931916284881,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,476.897352914457,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,476.897352914457,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),0.98708508780542,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.0172224261211321,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,1509.42372151016,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,1509.42372151016,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),1.71661244834932,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00582542670572843,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,26222.9388250107,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,26222.9388250107,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),17.3136185255082,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000635338013471513,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_int_Spleen_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_bc|Surface area (blood cells/plasma),3216.2517477184,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Surface area (plasma/interstitial),648.795846675263,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Spleen_pls_Spleen_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Midazolam|Partition coefficient (intracellular/plasma),0.016,R * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Midazolam|SalivaPlasmaRatio,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Itraconazole|Partition coefficient (intracellular/plasma),0.006016197247,R * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Itraconazole|SalivaPlasmaRatio,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),0.017,R * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Hydroxy-Itraconazole|SalivaPlasmaRatio,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Keto-Itraconazole|Partition coefficient (intracellular/plasma),0.01,R * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|Keto-Itraconazole|SalivaPlasmaRatio,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),0.011,R * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Saliva_slv_Saliva_slv|N-desalkyl-Itraconazole|SalivaPlasmaRatio,1,1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Surface area (interstitial/intracellular),27.905516892085,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P*SA interstitial -> intracellular,0.017115366692165,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P*SA intracellular -> interstitial,0.017115366692165,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|P*SA interstitial -> intracellular,0.144960033129196,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|P*SA intracellular -> interstitial,0.144960033129196,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00296940619662516,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00296940619662516,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00939844208527036,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00939844208527036,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.163277394107651,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.163277394107651,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_int_Duodenum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_bc|Surface area (blood cells/plasma),100.337311863768,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Surface area (plasma/interstitial),20.2404650848473,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_Duodenum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Surface area (interstitial/intracellular),91.4006808191366,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P*SA interstitial -> intracellular,0.0560590285491813,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P*SA intracellular -> interstitial,0.0560590285491813,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|P*SA interstitial -> intracellular,0.474796642212749,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|P*SA intracellular -> interstitial,0.474796642212749,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00972588141082179,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00972588141082179,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.03078330383755,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.03078330383755,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.534792637653907,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.534792637653907,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_int_UpperJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_bc|Surface area (blood cells/plasma),287.172306368717,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Surface area (plasma/interstitial),57.9296069669768,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperJejunum_pls_UpperJejunum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Surface area (interstitial/intracellular),71.1793034319165,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P*SA interstitial -> intracellular,0.0436565960717133,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P*SA intracellular -> interstitial,0.0436565960717133,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|P*SA interstitial -> intracellular,0.369753200541155,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|P*SA intracellular -> interstitial,0.369753200541155,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00757413903134491,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00757413903134491,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.023972842487089,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.023972842487089,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.416475753654917,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.416475753654917,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_int_LowerJejunum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_bc|Surface area (blood cells/plasma),212.207648079694,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Surface area (plasma/interstitial),42.8074204093323,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerJejunum_pls_LowerJejunum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Surface area (interstitial/intracellular),66.3261490263844,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P*SA interstitial -> intracellular,0.040679997659808,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P*SA intracellular -> interstitial,0.040679997659808,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|P*SA interstitial -> intracellular,0.344542650737415,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|P*SA intracellular -> interstitial,0.344542650737415,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00705771832426052,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00705771832426052,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.022338323736275,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.022338323736275,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.388079562048729,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.388079562048729,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_int_UpperIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_bc|Surface area (blood cells/plasma),186.834994504948,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Surface area (plasma/interstitial),37.6891418821295,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|UpperIleum_pls_UpperIleum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Surface area (interstitial/intracellular),31.5453664128938,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P*SA interstitial -> intracellular,0.0193478055139885,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P*SA intracellular -> interstitial,0.0193478055139885,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|P*SA interstitial -> intracellular,0.163867860895374,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|P*SA intracellular -> interstitial,0.163867860895374,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00335671999423979,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00335671999423979,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.0106243256642312,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.0106243256642312,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.184574442537175,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.184574442537175,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_int_LowerIleum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_bc|Surface area (blood cells/plasma),89.9575899468269,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Surface area (plasma/interstitial),18.1466238691735,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|LowerIleum_pls_LowerIleum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Surface area (interstitial/intracellular),2.28204581730992,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P*SA interstitial -> intracellular,0.00139965337759641,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P*SA intracellular -> interstitial,0.00139965337759641,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|P*SA interstitial -> intracellular,0.011854481626657,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|P*SA intracellular -> interstitial,0.011854481626657,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.000242830871655512,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.000242830871655512,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.000768581909192446,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.000768581909192446,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.0133524311957939,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.0133524311957939,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_int_Caecum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_bc|Surface area (blood cells/plasma),40.6590206519634,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Surface area (plasma/interstitial),8.20190886723685,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_Caecum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Surface area (interstitial/intracellular),8.86293406514235,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P*SA interstitial -> intracellular,0.00543592749347772,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P*SA intracellular -> interstitial,0.00543592749347772,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|P*SA interstitial -> intracellular,0.0460400436470439,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|P*SA intracellular -> interstitial,0.0460400436470439,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.000943098507549185,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.000943098507549185,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00298499299758309,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00298499299758309,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.0518577306380169,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.0518577306380169,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_int_ColonAscendens_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_bc|Surface area (blood cells/plasma),74.5415410619485,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Surface area (plasma/interstitial),15.0368335687882,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_ColonAscendens_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Surface area (interstitial/intracellular),13.6930569430801,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P*SA interstitial -> intracellular,0.00839839991582396,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P*SA intracellular -> interstitial,0.00839839991582396,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|P*SA interstitial -> intracellular,0.0711309521979094,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|P*SA intracellular -> interstitial,0.0711309521979094,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.00145706844617008,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.00145706844617008,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00461175484215271,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00461175484215271,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.0801191629483106,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.0801191629483106,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_int_ColonTransversum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_bc|Surface area (blood cells/plasma),156.710075853742,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Surface area (plasma/interstitial),31.6122164311919,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_ColonTransversum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Surface area (interstitial/intracellular),6.6415380370092,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P*SA interstitial -> intracellular,0.00407347261629171,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P*SA intracellular -> interstitial,0.00407347261629171,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|P*SA interstitial -> intracellular,0.0345006178382863,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|P*SA intracellular -> interstitial,0.0345006178382863,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.000706721336805288,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.000706721336805288,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00223683764179462,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00223683764179462,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.038860166172277,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.038860166172277,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_int_ColonDescendens_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_bc|Surface area (blood cells/plasma),78.3550379268712,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Surface area (plasma/interstitial),15.806108215596,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_ColonDescendens_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Surface area (interstitial/intracellular),8.21854246352471,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P*SA interstitial -> intracellular,0.00504070103708602,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P*SA intracellular -> interstitial,0.00504070103708602,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|P*SA interstitial -> intracellular,0.0426926400393665,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|P*SA intracellular -> interstitial,0.0426926400393665,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.000874529255730762,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.000874529255730762,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00276796504674962,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00276796504674962,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.0480873442336415,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.0480873442336415,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_bc|Surface area (blood cells/plasma),62.9638697626644,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Surface area (plasma/interstitial),12.701336958961,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_ColonSigmoid_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Surface area (interstitial/intracellular),3.84643425864822,Aeff / MicrovilliFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular),0.000613332724075773,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial),0.000613332724075773,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P*SA interstitial -> intracellular,0.00235914400183509,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P*SA intracellular -> interstitial,0.00235914400183509,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Midazolam|Partition coefficient (interstitial/water),0.042163173166682,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|P (interstitial->intracellular),0.00519467292757124,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|P (intracellular->interstitial),0.00519467292757124,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|P*SA interstitial -> intracellular,0.0199809679110825,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|P*SA intracellular -> interstitial,0.0199809679110825,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Itraconazole|Partition coefficient (interstitial/water),0.0161048689416368,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|P (interstitial->intracellular),0.000106409288461071,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|P (intracellular->interstitial),0.000106409288461071,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|P*SA interstitial -> intracellular,0.000409296332575045,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|P*SA intracellular -> interstitial,0.000409296332575045,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Hydroxy-Itraconazole|Partition coefficient (interstitial/water),0.0447285484907193,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|P (interstitial->intracellular),0.00033679512626896,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|P (intracellular->interstitial),0.00033679512626896,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|P*SA interstitial -> intracellular,0.00129546031182668,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|P*SA intracellular -> interstitial,0.00129546031182668,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|Keto-Itraconazole|Partition coefficient (interstitial/water),0.0266011356556834,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|P (interstitial->intracellular),0.00585107936681733,P * P_int_cell_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|P (intracellular->interstitial),0.00585107936681733,P * P_cell_int_factor * P_int_scalefactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|P*SA interstitial -> intracellular,0.0225057921265959,P_int_cell * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|P*SA intracellular -> interstitial,0.0225057921265959,P_cell_int * SA,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|P_cell_int_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|P_int_cell_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,((1+X)/(1+Y)*f_iw + f_ew + (10^LogP*f_nl+(0.3*10^LogP+0.7)*f_np)/(1+Y) + (HasStrongBase ? Ka_AP*AP_T*X/(1+Y) : Ka_PR*(IsNeutral ? PR_T2PR_P_Lipoprotein : PR_T2PR_P_Albumin)))*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,fu/K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_int_Rectum_cell|N-desalkyl-Itraconazole|Partition coefficient (interstitial/water),0.0292152119465357,fu/K_int_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_bc|Surface area (blood cells/plasma),25.6519469403447,HCT * A_to_V_bc * 0.6 * V * f_vas,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Surface area (plasma/interstitial),5.1746187610582,k * f_vas_org * V_org,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Midazolam|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Midazolam|Partition coefficient (interstitial/plasma),0.37947808,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Itraconazole|Partition coefficient (interstitial/plasma),0.373563874925178,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Hydroxy-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Hydroxy-Itraconazole|Partition coefficient (interstitial/plasma),0.38007046,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Keto-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|Keto-Itraconazole|Partition coefficient (interstitial/plasma),0.3759238,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|N-desalkyl-Itraconazole|P (plasma<->interstitial),10,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Rectum_pls_Rectum_int|N-desalkyl-Itraconazole|Partition coefficient (interstitial/plasma),0.37651618,(f_water_int + f_proteins_int_to_pls * (1/fu - f_water_pls)) * fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Midazolam|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Hydroxy-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|Keto-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_pls|N-desalkyl-Itraconazole|DrugAbsorption_para|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_F1,0.41450132132819,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K1,0.41450132132819,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K2,0.58549867867181,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.995013121263312,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.995013121263312,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00498687873668791,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.995013121263312,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.995013121263312,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00498687873668791,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.995013121263312,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.995013121263312,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00498687873668791,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.99684769081674,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999989035338264,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.996836760719007,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00315227461925627,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,1.09300977324518E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.45640038827887E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_duo_Duodenum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Duodenum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Midazolam|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|Keto-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_F1,0.261890967459581,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K1,0.261890967459581,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K2,0.738109032540419,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.993729987658566,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999994504621461,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.993724526736118,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00626997788534261,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,5.4609224478499E-06,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.44560912610767E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_cae_Caecum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Caecum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Midazolam|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|Keto-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_F1,0.219870396006841,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K1,0.219870396006841,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K2,0.780129603993159,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_F1,0.987567264745558,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K1,0.987567264745558,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K2,0.0124327352544424,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.987567264745558,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.987567264745558,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.0124327352544424,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.987567264745558,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.987567264745558,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.0124327352544424,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.99211931614967,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999995634860732,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.992114985410684,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00788064945004772,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.33073898529327E-06,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.44002825323962E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colasc_ColonAscendens_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonAscendens_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Midazolam|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|Keto-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_F1,0.261890967459581,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K1,0.261890967459581,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K2,0.738109032540419,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.99009900990099,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.99009900990099,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00990099009900991,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.993729987658566,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999994504621461,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.993724526736118,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.00626997788534261,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,5.4609224478499E-06,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.44560912610767E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coltrans_ColonTransversum_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonTransversum_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Midazolam|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|Keto-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_F1,0.738109032540418,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K1,0.738109032540418,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K2,0.261890967459582,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999206302221831,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999956350322153,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999162687188637,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000793663133516853,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.3615033194211E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46446523245957E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_coldesc_ColonDescendens_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonDescendens_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Midazolam|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Hydroxy-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|Keto-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_para*Aeff*(min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_para ? fu*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_pls|N-desalkyl-Itraconazole|Sum of passive process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|Partition coefficient (intracellular/plasma),0.997931517439377,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|Partition coefficient (intracellular/water),0.0160331643207892,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_F1,0.933885938662804,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K1,0.933885938662804,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K2,0.0661140613371957,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_F1,0.738109032540418,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K1,0.738109032540418,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K2,0.261890967459582,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Midazolam|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|Partition coefficient (intracellular/plasma),10.4462224593872,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|Partition coefficient (intracellular/water),0.000575920843193772,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/plasma),3.77262541635122,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|Partition coefficient (intracellular/water),0.00450614575364918,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Hydroxy-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|Partition coefficient (intracellular/plasma),6.76332364927184,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|Partition coefficient (intracellular/water),0.00147856298449899,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_F1,0.999748874436739,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K1,0.999748874436739,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K2,0.000251125563261345,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_F1,0.998742657488645,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K1,0.998742657488645,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K2,0.00125734251135523,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|Keto-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|Drug absorption rate (lumen to mucosa),0,OralApplicationsEnabled ? P_int_trans*Aeff*(P_int_trans_lum_cell_factor*min(Solubility/ MW ;DrugLiquid/(Liquid))-(NOT SinkCondition_trans ? P_int_trans_cell_lum_factor*fu/K_cell_pls*DrugMucosa : 0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|P_int_trans_cell_lum_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|P_int_trans_lum_cell_factor,1,UsePenaltyFactor ? K1+ (K2 +K3 +K4)* base ^ 1 + K5* base ^ max(CT0+CT1;-CT0-CT1) +K6* base ^ max(CT0+CT2;-CT0-CT2) +K7* base ^ max(CT2+CT1;-CT2-CT1) +K8* base ^ max(CT0+CT1+CT2;-CT0-CT1-CT2) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/plasma),69.2040559388767,K_cell_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|Partition coefficient (intracellular/water),0.000158950221208357,K_water_cell,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F1,0.999841535795638,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F2,0.999781271690145,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K1,0.999622842146391,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K2,0.000158429543754682,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K3,0.000218693649246995,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K5,3.46606075926122E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_cell_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F1,0.999206302221831,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F2,0.999956350322153,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K1,0.999162687188637,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K2,0.000793663133516853,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K3,4.3615033194211E-05,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K5,3.46446523245957E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|pKa_pH_WS_lum_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|Sum of active process rates,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|Sum of passive process rates,0,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|Lumen_colsigm_ColonSigmoid_cell|N-desalkyl-Itraconazole|DrugAbsorption_trans|ProcessRate,0,DrugAbsorptionLumenToMucosaRate,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_PortalVein_pls|Midazolam|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_PortalVein_pls|Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_PortalVein_pls|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_PortalVein_pls|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_pls_PortalVein_pls|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein plasma),0,Q*(1-HCT)*C_pls,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_bc_PortalVein_bc|Midazolam|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_bc_PortalVein_bc|Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_bc_PortalVein_bc|Hydroxy-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_bc_PortalVein_bc|Keto-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Neighborhoods|ColonSigmoid_bc_PortalVein_bc|N-desalkyl-Itraconazole|Mass transfer rate (mucosa to portal vein blood cells),0,Q*HCT*C_bc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Default Intestinal permeability (transcellular),1.05909030308125E-05,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Intestinal permeability (paracellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Intestinal permeability (transcellular),2E-06,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Mucosa permeability scale factor (transcellular),0.188841309771351,P_int_trans_default >0 ? P_int_trans / P_int_trans_default : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|P (blood cells->plasma),0.00324787370315529,P * P_rbc_pls_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|P (plasma->blood cells),0.00324787370315529,P * P_pls_rbc_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|P_bc_pls_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|P_pls_bc_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Partition coefficient (blood cells/plasma),0.273578902365443,K_pu_bc*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Fraction unbound (plasma),0.016,1 / (1 + (BindingPartner = Albumin ? AlbuminOntgenyFactor : (BindingPartner = Agp ? AgpOntogenyFactor : 1) ) * (1 - fu_ref) / fu_ref) * PlasmaProteinScaleFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Blood/Plasma concentration ratio,0.658582084111758,(f_water_rbc + f_lipids_rbc * 10^LogP + f_proteins_rbc * KProt) * fu * HCT - HCT + 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Calculated specific intestinal permeability (transcellular),1.05909030308125E-05,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Compound type 0,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Effective molecular weight,3.2577E-07,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is floating in lumen,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is monoprotic base,1,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is neutral,0,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Molecular weight,3.2577E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa value 0,6.15,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Base_0,6.15,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_Bases_Count,1,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_OneBase_0,6.15,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_F1,0.691236152414763,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K1,0.691236152414763,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K2,0.308763847585237,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Solubility_pKa_pH_Factor,0.691544916262348,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Total drug mass,23.0223777511741,P_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Lipophilicity,3.13,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Fraction unbound (plasma, reference value),0.016,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Solubility at reference pH,4.9E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Reference pH,6.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Permeability,0.00324787370315529,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Specific intestinal permeability (transcellular),2E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Partition coefficient (water/protein),29.9349753380983,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Aqueous diffusion coefficient,3.21329449496253E-06,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Radius (solute),3.84061221838702E-09,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Ka (acidic phospholipids),297.229510166159,Max(0;Kpu_bc - (1+Z)/(1+Y)*f_iw_bc - (10^LogP*f_nl_bc + (0.3*10^LogP+0.7)*f_np_bc)/(1+Y)) * (1+Y) / AP_bc / Z,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Ka (proteins),56.6071474768565,Max(0;1/fu - 1 - (10^LogP*f_nl_p + (0.3*10^LogP+0.7)*f_np_p)/(1+Y)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|logP (veg.oil/water),2.13995,1.115 * LogP - 1.35,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Partition coefficient (blood cells/plasma unbound),17.0986813978402,(HCT - 1 + B2P) / fu / HCT,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X,0.141253754462276,X_Neutral + X_MonoproticBase + X_MonoproticAcid + X_DiproticBase + X_DiproticAcid + X_MonoproticBaseMonoproticAcid + X_TriproticAcid + X_TriproticBase + X_DiproticBaseMonoproticAcid + X_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_DiproticAcid,0,IsDiproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_MonoproticBase,0.141253754462276,IsMonoproticBase ? 10^(pKa_Base_0-pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_TriproticAcid,0,IsTriproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_IW-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|X_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_IW) + 10^(pKa_Base_2+pKa_Base_1-2*pH_IW) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y,0.0562341325190349,Y_Neutral + Y_MonoproticBase + Y_MonoproticAcid + Y_DiproticBase + Y_DiproticAcid + Y_MonoproticBaseMonoproticAcid + Y_TriproticAcid + Y_TriproticBase + Y_DiproticBaseMonoproticAcid + Y_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_DiproticAcid,0,IsDiproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_MonoproticBase,0.0562341325190349,IsMonoproticBase ? 10^(pKa_Base_0-pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_TriproticAcid,0,IsTriproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_PLS-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Y_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_PLS) + 10^(pKa_Base_2+pKa_Base_1-2*pH_PLS) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z,0.0851138038202378,Z_Neutral + Z_MonoproticBase + Z_MonoproticAcid + Z_DiproticBase + Z_DiproticAcid + Z_MonoproticBaseMonoproticAcid + Z_TriproticAcid + Z_TriproticBase + Z_DiproticBaseMonoproticAcid + Z_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_DiproticAcid,0,IsDiproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_RBC-pKa_Acid_0) + 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_MonoproticAcid,0,IsMonoproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_MonoproticBase,0.0851138038202378,IsMonoproticBase ? 10^(pKa_Base_0-pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) + 10^(2*pH_RBC-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_Neutral,0,IsNeutral ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_TriproticAcid,0,IsTriproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Z_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_RBC) + 10^(pKa_Base_2+pKa_Base_1-2*pH_RBC) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Parameter m for correlation of intestinal permeability (transcellular),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam|Parameter b for correlation of intestinal permeability (transcellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Default Intestinal permeability (transcellular),1.02023066824998E-05,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Intestinal permeability (paracellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Intestinal permeability (transcellular),5.4E-05,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Mucosa permeability scale factor (transcellular),5.29292067769606,P_int_trans_default >0 ? P_int_trans / P_int_trans_default : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|P (blood cells->plasma),0.000981437894858537,P * P_rbc_pls_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|P (plasma->blood cells),0.000981437894858537,P * P_pls_rbc_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|P_bc_pls_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|P_pls_bc_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Partition coefficient (blood cells/plasma),3.08718412337602,K_pu_bc*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Fraction unbound (plasma),0.006016197247,1 / (1 + (BindingPartner = Albumin ? AlbuminOntgenyFactor : (BindingPartner = Agp ? AgpOntogenyFactor : 1) ) * (1 - fu_ref) / fu_ref) * PlasmaProteinScaleFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Blood/Plasma concentration ratio,1.98097653798673,(f_water_rbc + f_lipids_rbc * 10^LogP + f_proteins_rbc * KProt) * fu * HCT - HCT + 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Calculated specific intestinal permeability (transcellular),1.02023066824998E-05,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Compound type 0,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Effective molecular weight,7.05633E-07,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is floating in lumen,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is monoprotic base,1,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is neutral,0,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Molecular weight,7.05633E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa value 0,3.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Base_0,3.7,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_Bases_Count,1,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_OneBase_0,3.7,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_F1,0.998417614719198,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K1,0.998417614719198,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K2,0.00158238528080179,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Solubility_pKa_pH_Factor,0.998419197104479,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Total drug mass,566.866912403473,P_1 + P_2 + P_3 + P_4,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Lipophilicity,4.624270461,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Fraction unbound (plasma, reference value),0.006016197247,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Solubility at reference pH,6.9E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Reference pH,6.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Permeability,0.000981437894858537,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Specific intestinal permeability (transcellular),5.4E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Partition coefficient (water/protein),929.31098239356,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Aqueous diffusion coefficient,2.25030426442644E-06,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Radius (solute),5.32419152125911E-09,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Ka (acidic phospholipids),2442346.38615955,Max(0;Kpu_bc - (1+Z)/(1+Y)*f_iw_bc - (10^LogP*f_nl_bc + (0.3*10^LogP+0.7)*f_np_bc)/(1+Y)) * (1+Y) / AP_bc / Z,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Ka (proteins),4.00996935195056,Max(0;1/fu - 1 - (10^LogP*f_nl_p + (0.3*10^LogP+0.7)*f_np_p)/(1+Y)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|logP (veg.oil/water),3.806061564015,1.115 * LogP - 1.35,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Partition coefficient (blood cells/plasma unbound),513.145430016521,(HCT - 1 + B2P) / fu / HCT,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X,0.000501187233627273,X_Neutral + X_MonoproticBase + X_MonoproticAcid + X_DiproticBase + X_DiproticAcid + X_MonoproticBaseMonoproticAcid + X_TriproticAcid + X_TriproticBase + X_DiproticBaseMonoproticAcid + X_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_DiproticAcid,0,IsDiproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_MonoproticBase,0.000501187233627273,IsMonoproticBase ? 10^(pKa_Base_0-pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_TriproticAcid,0,IsTriproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_IW-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|X_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_IW) + 10^(pKa_Base_2+pKa_Base_1-2*pH_IW) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y,0.000199526231496888,Y_Neutral + Y_MonoproticBase + Y_MonoproticAcid + Y_DiproticBase + Y_DiproticAcid + Y_MonoproticBaseMonoproticAcid + Y_TriproticAcid + Y_TriproticBase + Y_DiproticBaseMonoproticAcid + Y_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_DiproticAcid,0,IsDiproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_MonoproticBase,0.000199526231496888,IsMonoproticBase ? 10^(pKa_Base_0-pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_TriproticAcid,0,IsTriproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_PLS-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Y_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_PLS) + 10^(pKa_Base_2+pKa_Base_1-2*pH_PLS) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z,0.000301995172040202,Z_Neutral + Z_MonoproticBase + Z_MonoproticAcid + Z_DiproticBase + Z_DiproticAcid + Z_MonoproticBaseMonoproticAcid + Z_TriproticAcid + Z_TriproticBase + Z_DiproticBaseMonoproticAcid + Z_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_DiproticAcid,0,IsDiproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_RBC-pKa_Acid_0) + 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_MonoproticAcid,0,IsMonoproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_MonoproticBase,0.000301995172040202,IsMonoproticBase ? 10^(pKa_Base_0-pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) + 10^(2*pH_RBC-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_Neutral,0,IsNeutral ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_TriproticAcid,0,IsTriproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Z_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_RBC) + 10^(pKa_Base_2+pKa_Base_1-2*pH_RBC) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Parameter m for correlation of intestinal permeability (transcellular),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|Parameter b for correlation of intestinal permeability (transcellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole|CYP3A4-Isoherranen, 2004|Ki,0.0013,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Default Intestinal permeability (transcellular),1.14398767055627E-06,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Intestinal permeability (paracellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Intestinal permeability (transcellular),1.14398767055627E-06,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Mucosa permeability scale factor (transcellular),1,P_int_trans_default >0 ? P_int_trans / P_int_trans_default : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|P (blood cells->plasma),0.000106409288461071,P * P_rbc_pls_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|P (plasma->blood cells),0.000106409288461071,P * P_pls_rbc_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|P_bc_pls_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|P_pls_bc_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Partition coefficient (blood cells/plasma),1.0921032900233,K_pu_bc*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Fraction unbound (plasma),0.017,1 / (1 + (BindingPartner = Albumin ? AlbuminOntgenyFactor : (BindingPartner = Agp ? AgpOntogenyFactor : 1) ) * (1 - fu_ref) / fu_ref) * PlasmaProteinScaleFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Blood/Plasma concentration ratio,1.04328854631095,(f_water_rbc + f_lipids_rbc * 10^LogP + f_proteins_rbc * KProt) * fu * HCT - HCT + 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Calculated specific intestinal permeability (transcellular),1.14398767055627E-06,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Compound type 0,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Effective molecular weight,7.21633E-07,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is floating in lumen,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is monoprotic base,1,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is neutral,0,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Molecular weight,7.21633E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa value 0,3.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Base_0,3.7,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_Bases_Count,1,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_OneBase_0,3.7,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_F1,0.999499063829186,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K1,0.999499063829186,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K2,0.000500936170813704,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Solubility_pKa_pH_Factor,0.999499564765357,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Lipophilicity,3.7178121898,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Fraction unbound (plasma, reference value),0.017,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Solubility at reference pH,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Permeability,0.000106409288461071,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Specific intestinal permeability (transcellular),1.14398767055627E-06,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Partition coefficient (water/protein),115.408780289282,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Aqueous diffusion coefficient,2.22716928444606E-06,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Radius (solute),5.37487956993378E-09,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Ka (acidic phospholipids),303165.979378154,Max(0;Kpu_bc - (1+Z)/(1+Y)*f_iw_bc - (10^LogP*f_nl_bc + (0.3*10^LogP+0.7)*f_np_bc)/(1+Y)) * (1+Y) / AP_bc / Z,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Ka (proteins),37.8269256907149,Max(0;1/fu - 1 - (10^LogP*f_nl_p + (0.3*10^LogP+0.7)*f_np_p)/(1+Y)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|logP (veg.oil/water),2.795360591627,1.115 * LogP - 1.35,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Partition coefficient (blood cells/plasma unbound),64.2413700013706,(HCT - 1 + B2P) / fu / HCT,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X,0.000501187233627273,X_Neutral + X_MonoproticBase + X_MonoproticAcid + X_DiproticBase + X_DiproticAcid + X_MonoproticBaseMonoproticAcid + X_TriproticAcid + X_TriproticBase + X_DiproticBaseMonoproticAcid + X_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_DiproticAcid,0,IsDiproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_MonoproticBase,0.000501187233627273,IsMonoproticBase ? 10^(pKa_Base_0-pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_TriproticAcid,0,IsTriproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_IW-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|X_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_IW) + 10^(pKa_Base_2+pKa_Base_1-2*pH_IW) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y,0.000199526231496888,Y_Neutral + Y_MonoproticBase + Y_MonoproticAcid + Y_DiproticBase + Y_DiproticAcid + Y_MonoproticBaseMonoproticAcid + Y_TriproticAcid + Y_TriproticBase + Y_DiproticBaseMonoproticAcid + Y_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_DiproticAcid,0,IsDiproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_MonoproticBase,0.000199526231496888,IsMonoproticBase ? 10^(pKa_Base_0-pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_TriproticAcid,0,IsTriproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_PLS-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Y_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_PLS) + 10^(pKa_Base_2+pKa_Base_1-2*pH_PLS) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z,0.000301995172040202,Z_Neutral + Z_MonoproticBase + Z_MonoproticAcid + Z_DiproticBase + Z_DiproticAcid + Z_MonoproticBaseMonoproticAcid + Z_TriproticAcid + Z_TriproticBase + Z_DiproticBaseMonoproticAcid + Z_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_DiproticAcid,0,IsDiproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_RBC-pKa_Acid_0) + 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_MonoproticAcid,0,IsMonoproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_MonoproticBase,0.000301995172040202,IsMonoproticBase ? 10^(pKa_Base_0-pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) + 10^(2*pH_RBC-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_Neutral,0,IsNeutral ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_TriproticAcid,0,IsTriproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Z_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_RBC) + 10^(pKa_Base_2+pKa_Base_1-2*pH_RBC) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Parameter m for correlation of intestinal permeability (transcellular),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|Parameter b for correlation of intestinal permeability (transcellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole|CYP3A4-Isoherranen, 2004|Ki,0.0144,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Default Intestinal permeability (transcellular),3.60566311245442E-06,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Intestinal permeability (paracellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Intestinal permeability (transcellular),3.60566311245442E-06,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Mucosa permeability scale factor (transcellular),1,P_int_trans_default >0 ? P_int_trans / P_int_trans_default : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|P (blood cells->plasma),0.00033679512626896,P * P_rbc_pls_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|P (plasma->blood cells),0.00033679512626896,P * P_pls_rbc_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|P_bc_pls_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|P_pls_bc_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Partition coefficient (blood cells/plasma),1.98513483542922,K_pu_bc*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Fraction unbound (plasma),0.01,1 / (1 + (BindingPartner = Albumin ? AlbuminOntgenyFactor : (BindingPartner = Agp ? AgpOntogenyFactor : 1) ) * (1 - fu_ref) / fu_ref) * PlasmaProteinScaleFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Blood/Plasma concentration ratio,1.46301337265173,(f_water_rbc + f_lipids_rbc * 10^LogP + f_proteins_rbc * KProt) * fu * HCT - HCT + 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Calculated specific intestinal permeability (transcellular),3.60566311245443E-06,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Compound type 0,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Effective molecular weight,7.19617E-07,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is floating in lumen,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is monoprotic base,1,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is neutral,0,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Molecular weight,7.19617E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa value 0,3.7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Base_0,3.7,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_Bases_Count,1,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_OneBase_0,3.7,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_F1,0.999499063829186,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K1,0.999499063829186,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K2,0.000500936170813704,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Solubility_pKa_pH_Factor,0.999499564765357,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Lipophilicity,4.2109086248,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Fraction unbound (plasma, reference value),0.01,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Solubility at reference pH,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Permeability,0.00033679512626896,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Specific intestinal permeability (transcellular),3.60566311245443E-06,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Partition coefficient (water/protein),358.855829730038,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Aqueous diffusion coefficient,2.2300428522102E-06,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Radius (solute),5.36852884914998E-09,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Ka (acidic phospholipids),943018.233010076,Max(0;Kpu_bc - (1+Z)/(1+Y)*f_iw_bc - (10^LogP*f_nl_bc + (0.3*10^LogP+0.7)*f_np_bc)/(1+Y)) * (1+Y) / AP_bc / Z,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Ka (proteins),36.7655278271167,Max(0;1/fu - 1 - (10^LogP*f_nl_p + (0.3*10^LogP+0.7)*f_np_p)/(1+Y)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|logP (veg.oil/water),3.345163116652,1.115 * LogP - 1.35,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Partition coefficient (blood cells/plasma unbound),198.513483542922,(HCT - 1 + B2P) / fu / HCT,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X,0.000501187233627273,X_Neutral + X_MonoproticBase + X_MonoproticAcid + X_DiproticBase + X_DiproticAcid + X_MonoproticBaseMonoproticAcid + X_TriproticAcid + X_TriproticBase + X_DiproticBaseMonoproticAcid + X_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_DiproticAcid,0,IsDiproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_MonoproticBase,0.000501187233627273,IsMonoproticBase ? 10^(pKa_Base_0-pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_TriproticAcid,0,IsTriproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_IW-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|X_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_IW) + 10^(pKa_Base_2+pKa_Base_1-2*pH_IW) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y,0.000199526231496888,Y_Neutral + Y_MonoproticBase + Y_MonoproticAcid + Y_DiproticBase + Y_DiproticAcid + Y_MonoproticBaseMonoproticAcid + Y_TriproticAcid + Y_TriproticBase + Y_DiproticBaseMonoproticAcid + Y_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_DiproticAcid,0,IsDiproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_MonoproticBase,0.000199526231496888,IsMonoproticBase ? 10^(pKa_Base_0-pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_TriproticAcid,0,IsTriproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_PLS-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Y_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_PLS) + 10^(pKa_Base_2+pKa_Base_1-2*pH_PLS) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z,0.000301995172040202,Z_Neutral + Z_MonoproticBase + Z_MonoproticAcid + Z_DiproticBase + Z_DiproticAcid + Z_MonoproticBaseMonoproticAcid + Z_TriproticAcid + Z_TriproticBase + Z_DiproticBaseMonoproticAcid + Z_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_DiproticAcid,0,IsDiproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_RBC-pKa_Acid_0) + 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_MonoproticAcid,0,IsMonoproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_MonoproticBase,0.000301995172040202,IsMonoproticBase ? 10^(pKa_Base_0-pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) + 10^(2*pH_RBC-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_MonoproticBaseMonoproticAcid,0,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_Neutral,0,IsNeutral ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_TriproticAcid,0,IsTriproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Z_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_RBC) + 10^(pKa_Base_2+pKa_Base_1-2*pH_RBC) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Parameter m for correlation of intestinal permeability (transcellular),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|Parameter b for correlation of intestinal permeability (transcellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole|CYP3A4-Isoherranen, 2004|Ki,0.00512,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Default Intestinal permeability (transcellular),5.37154266276729E-05,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Intestinal permeability (paracellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Intestinal permeability (transcellular),5.37154266276729E-05,10 ^ (m * log10 (P_int_InVitro) + b),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Mucosa permeability scale factor (transcellular),1,P_int_trans_default >0 ? P_int_trans / P_int_trans_default : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|P (blood cells->plasma),0.00585107936681733,P * P_rbc_pls_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|P (plasma->blood cells),0.00585107936681733,P * P_pls_rbc_factor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|P_bc_pls_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|P_pls_bc_factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Partition coefficient (blood cells/plasma),20.4503430380174,K_pu_bc*fu,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Fraction unbound (plasma),0.011,1 / (1 + (BindingPartner = Albumin ? AlbuminOntgenyFactor : (BindingPartner = Agp ? AgpOntogenyFactor : 1) ) * (1 - fu_ref) / fu_ref) * PlasmaProteinScaleFactor,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Blood/Plasma concentration ratio,10.1416612278682,(f_water_rbc + f_lipids_rbc * 10^LogP + f_proteins_rbc * KProt) * fu * HCT - HCT + 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Calculated specific intestinal permeability (transcellular),5.3715426627673E-05,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Compound type 0,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Compound type 1,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Effective molecular weight,6.49527E-07,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is floating in lumen,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is monoprotic base monoprotic acid,1,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is neutral,0,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Molecular weight,6.49527E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa value 0,3.5,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa value 1,10.96,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Acid_0,10.96,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Acids_Count,1,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Base_0,3.5,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_Bases_Count,1,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_OneAcid_0,10.96,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_OneBase_0,3.5,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_F1,0.99968387220237,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_F2,0.999890364201712,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K1,0.999574271063006,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K2,0.00031609313870623,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K3,0.000109601139364589,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K5,3.46589234541715E-08,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Solubility_pKa_pH_Factor,0.999574731416207,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Lipophilicity,5.1837535822,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Fraction unbound (plasma, reference value),0.011,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Solubility at reference pH,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Permeability,0.00585107936681733,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Specific intestinal permeability (transcellular),5.3715426627673E-05,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Partition coefficient (water/protein),3369.68403461635,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Aqueous diffusion coefficient,2.3378960480122E-06,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Radius (solute),5.14100248704984E-09,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Ka (acidic phospholipids),7181548.55967822,Max(0;Kpu_bc - (1+Z)/(1+Y)*f_iw_bc - (10^LogP*f_nl_bc + (0.3*10^LogP+0.7)*f_np_bc)/(1+Y)) * (1+Y) / AP_bc / Z,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Ka (proteins),0,Max(0;1/fu - 1 - (10^LogP*f_nl_p + (0.3*10^LogP+0.7)*f_np_p)/(1+Y)),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|logP (veg.oil/water),4.429885244153,1.115 * LogP - 1.35,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Partition coefficient (blood cells/plasma unbound),1859.12209436522,(HCT - 1 + B2P) / fu / HCT,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X,0.000425875585631156,X_Neutral + X_MonoproticBase + X_MonoproticAcid + X_DiproticBase + X_DiproticAcid + X_MonoproticBaseMonoproticAcid + X_TriproticAcid + X_TriproticBase + X_DiproticBaseMonoproticAcid + X_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_DiproticAcid,0,IsDiproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(pKa_Base_1-pH_IW) + 10^(pKa_Base_0+pKa_Base_1-2*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_MonoproticBase,0,IsMonoproticBase ? 10^(pKa_Base_0-pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_MonoproticBaseMonoproticAcid,0.000425875585631156,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_IW) + 10^(pH_IW-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_TriproticAcid,0,IsTriproticAcid ? 10^(pH_IW-pKa_Acid_0) + 10^(2*pH_IW-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_IW-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|X_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_IW) + 10^(pKa_Base_2+pKa_Base_1-2*pH_IW) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_IW) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y,0.000401315411513233,Y_Neutral + Y_MonoproticBase + Y_MonoproticAcid + Y_DiproticBase + Y_DiproticAcid + Y_MonoproticBaseMonoproticAcid + Y_TriproticAcid + Y_TriproticBase + Y_DiproticBaseMonoproticAcid + Y_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_DiproticAcid,0,IsDiproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(pKa_Base_1-pH_PLS) + 10^(pKa_Base_0+pKa_Base_1-2*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_MonoproticAcid,0,IsMonoproticAcid ? 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_MonoproticBase,0,IsMonoproticBase ? 10^(pKa_Base_0-pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_MonoproticBaseMonoproticAcid,0.000401315411513233,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_PLS) + 10^(pH_PLS-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_Neutral,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_TriproticAcid,0,IsTriproticAcid ? 10^(pH_PLS-pKa_Acid_0) + 10^(2*pH_PLS-pKa_Acid_0-pKa_Acid_1) + 10^(3*pH_PLS-pKa_Acid_0-pKa_Acid_1-pKa_Acid_2) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Y_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_PLS) + 10^(pKa_Base_2+pKa_Base_1-2*pH_PLS) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_PLS) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z,0.000372516157657323,Z_Neutral + Z_MonoproticBase + Z_MonoproticAcid + Z_DiproticBase + Z_DiproticAcid + Z_MonoproticBaseMonoproticAcid + Z_TriproticAcid + Z_TriproticBase + Z_DiproticBaseMonoproticAcid + Z_MonoproticBaseDiproticAcid,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_DiproticAcid,0,IsDiproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_DiproticBase,0,IsDiproticBase ? 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_DiproticBaseMonoproticAcid,0,IsDiproticBaseMonoproticAcid ? 10^(pH_RBC-pKa_Acid_0) + 10^(pKa_Base_1-pH_RBC) + 10^(pKa_Base_0+pKa_Base_1-2*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_MonoproticAcid,0,IsMonoproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_MonoproticBase,0,IsMonoproticBase ? 10^(pKa_Base_0-pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_MonoproticBaseDiproticAcid,0,IsMonoproticBaseDiproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) + 10^(2*pH_RBC-pKa_Acid_0-pKa_Acid_1) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_MonoproticBaseMonoproticAcid,0.000372516157657323,IsMonoproticBaseMonoproticAcid ? 10^(pKa_Base_0-pH_RBC) + 10^(pH_RBC-pKa_Acid_0) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_Neutral,0,IsNeutral ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_TriproticAcid,0,IsTriproticAcid ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Z_TriproticBase,0,IsTriproticBase ? 10^(pKa_Base_2-pH_RBC) + 10^(pKa_Base_2+pKa_Base_1-2*pH_RBC) + 10^(pKa_Base_0+pKa_Base_1+pKa_Base_2-3*pH_RBC) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Parameter m for correlation of intestinal permeability (transcellular),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|Parameter b for correlation of intestinal permeability (transcellular),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole|CYP3A4-Isoherranen, 2004|Ki,0.00032,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Ontogeny factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Ontogeny factor GI,0.974126058257768,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Reference concentration,4.32,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Rel. exp. variability factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Relative expression in blood cells,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Relative expression in blood cells (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|t1/2 (intestine),1380,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|t1/2 (liver),2160,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Relative expression in plasma,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Relative expression in plasma (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Relative expression in vascular endothelium,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Relative expression in vascular endothelium (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|CYP3A4|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Ontogeny factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Ontogeny factor GI,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Reference concentration,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Rel. exp. variability factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Relative expression in blood cells,3.9102564103E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Relative expression in blood cells (normalized),3.9102564103E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|t1/2 (intestine),1380,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|t1/2 (liver),2160,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Relative expression in plasma,3.9102564103E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Relative expression in plasma (normalized),3.9102564103E-05,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Relative expression in vascular endothelium,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Relative expression in vascular endothelium (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|AADAC|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Ontogeny factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Ontogeny factor GI,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Reference concentration,0.47661714,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Rel. exp. variability factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Relative expression in blood cells,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Relative expression in blood cells (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|t1/2 (intestine),1380,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|t1/2 (liver),2160,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Relative expression in plasma,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Relative expression in plasma (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Relative expression in vascular endothelium,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Relative expression in vascular endothelium (normalized),0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ATP1A2|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al. Metabolite|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004 Metabolite|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Ontogeny factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Ontogeny factor GI,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Reference concentration,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Rel. exp. variability factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|t1/2 (intestine),1380,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|t1/2 (liver),2160,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|OATP1B1|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Ontogeny factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Ontogeny factor GI,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Reference concentration,1.41,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Rel. exp. variability factor,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|t1/2 (intestine),1380,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|t1/2 (liver),2160,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|base_For_KaPL_Factor,20,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|base_For_logD_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|base_For_P_cell_Factor,0.001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|base_For_Pint_Factor,0.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|BP_AGP,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|BP_ALBUMIN,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|BP_UNKNOWN,2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Br,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Calculated specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Cl,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Compound type 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Compound type 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Compound type 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|CT_ACID,-1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|CT_BASE,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|CT_NEUTRAL,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Effective molecular weight,NaN,MW - F * 0.000000017 - Cl * 0.000000022 - Br * 0.000000062 - I * 0.000000098,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|F,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Has halogens,0,Br + Chlor + F + I > 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|I,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is diprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is diprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 2 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is floating in lumen,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is monoprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is monoprotic base diprotic acid,0,pKa_Acids_Count=2 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is monoprotic base monoprotic acid,0,pKa_Acids_Count=1 & pKa_Bases_Count = 1 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is neutral,1,CT_0 = 0 AND CT_1 = 0 AND CT_2 = 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is small molecule,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is strong base,0,(CT_0=1 AND pKa_0>=7) OR (CT_1=1 AND pKa_1>=7) OR (CT_2=1 AND pKa_2>=7),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is triprotic acid,0,pKa_Acids_Count=3 & pKa_Bases_Count = 0 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Is triprotic base,0,pKa_Acids_Count=0 & pKa_Bases_Count = 3 ? 1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Molecular weight,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa value 0,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa value 1,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa value 2,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Acid_0,0,pKa_OneAcid_0+pKa_TwoAcids_0+pKa_ThreeAcids_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Acid_1,0,pKa_TwoAcids_1+pKa_ThreeAcids_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Acid_2,0,IsTriproticAcid ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Acids_Count,0,(CT0 = CT_ACID ? 1 : 0) + (CT1 = CT_ACID ? 1 : 0) + (CT2 = CT_ACID ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Base_0,0,pKa_OneBase_0+pKa_TwoBases_0+pKa_ThreeBases_0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Base_1,0,pKa_TwoBases_1+pKa_ThreeBases_1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Base_2,0,IsTriproticBase ? Max (pKa_0; Max (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_Bases_Count,0,(CT0 = CT_BASE ? 1 : 0) + (CT1 = CT_BASE ? 1 : 0) + (CT2 = CT_BASE ? 1 : 0),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_OneAcid_0,0,pKa_Acids_Count=1 ? (CT0=CT_ACID ? pKa_0 : (CT1=CT_ACID ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_OneBase_0,0,pKa_Bases_Count=1 ? (CT0=CT_BASE ? pKa_0 : (CT1=CT_BASE ? pKa_1 : pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_F1,1,CT0 != CT_NEUTRAL ?  1/(1+10^(CT0*(pKa_0-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_F2,1,CT1 != CT_NEUTRAL ?  1/(1+10^(CT1*(pKa_1-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_F3,1,CT2 != CT_NEUTRAL ?  1/(1+10^(CT2*(pKa_2-pH))) : 1,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K1,1,F1*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K2,0,(1-F1)*F2*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K3,0,F1*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K4,0,F1*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K5,0,(1-F1)*(1-F2)*F3,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K6,0,(1-F1)*F2*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K7,0,F1*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_pH_WS_sol_K8,0,(1-F1)*(1-F2)*(1-F3),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_ThreeAcids_0,0,IsTriproticAcid ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_ThreeAcids_1,0,IsTriproticAcid ? (pKa_0 <= pKa_Acid_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Acid_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_ThreeBases_0,0,IsTriproticBase ? Min (pKa_0; Min (pKa_1; pKa_2)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_ThreeBases_1,0,IsTriproticBase ? (pKa_0 <= pKa_Base_0 ? min(pKa_1; pKa_2) : (pKa_0 >= pKa_Base_2 ? max(pKa_1; pKa_2) : pKa_0)) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_TwoAcids_0,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Min(pKa_1;pKa_2) : (CT1 != CT_ACID ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_TwoAcids_1,0,pKa_Acids_Count=2 ? (CT0 != CT_ACID ? Max(pKa_1;pKa_2) : (CT1 != CT_ACID ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_TwoBases_0,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Min(pKa_1;pKa_2) : (CT1 != CT_BASE ? Min(pKa_0;pKa_2) : Min(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|pKa_TwoBases_1,0,pKa_Bases_Count=2 ? (CT0 != CT_BASE ? Max(pKa_1;pKa_2) : (CT1 != CT_BASE ? Max(pKa_0;pKa_2) : Max(pKa_0;pKa_1))) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Plasma protein binding partner,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Solubility_pKa_pH_Factor,1,K1+K2/base^(CT0^2)+K3/base^(CT1^2)+K4/base^(CT2^2)+K5/base^max(CT0+CT1;-CT0-CT1)+K6/base^max(CT0+CT2;-CT0-CT2)+K7/base^max(CT1+CT2;-CT1-CT2)+K8/base^max(CT0+CT1+CT2;-CT0-CT1-CT2),
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Total drug mass,0,0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Total oral drug mass,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Lipophilicity,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Fraction unbound (plasma, reference value),NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Solubility at reference pH,NaN,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Solubility table,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Reference pH,7,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Solubility gain per charge,1000,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Permeability,NaN,IsSmallMolecule ? (MWEff *1E9 / 336) ^ (-6) * 10^LogMA / 5 * 1E-4 *1E-1: 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Specific intestinal permeability (transcellular),NaN,IsSmallMolecule ? 266 * (MWEff * 1E9) ^ ( - 4.5) * 10^LogMA * 60 *1E-1 : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Partition coefficient (water/protein),NaN,(0.81 + 0.11 * 10^LogMA) / 24.92 * 5.0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Treat precipitated drug as,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Aqueous diffusion coefficient,NaN,60 * 10^(-4.113-0.4609*Log10(MW * 1E9)) *1E-2,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Density (drug),1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Immediately dissolve particles smaller than,1E-07,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Radius (solute),NaN,0,0333 * (MW * 1E9) ^ 0,4226 * 1E-8,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Kd (FcRn) in endosomal space,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Kd (FcRn) in plasma/interstitial,999999,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|kass (FcRn),0.87,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|ABCB1|Use pH- and pKa-dependent penalty factor for charged molecule fraction,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al.|Enzyme concentration,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al.|Vmax,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al.|Km,2.73,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Midazolam-CYP3A4-Patki et al.|kcat,13,Vmax / EnzymeConcentration,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole-CYP3A4-Isoherranen 2004|In vitro Vmax/recombinant enzyme,0.27,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole-CYP3A4-Isoherranen 2004|Km,0.0020688492598,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Itraconazole-CYP3A4-Isoherranen 2004|kcat,0.0402937875,InVitroVmaxPerRecombinantEnzyme,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|In vitro Vmax/recombinant enzyme,0.543,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|Km,0.0041716224833,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Hydroxy-Itraconazole-CYP3A4-Isoherranen 2004|kcat,0.0203370845,InVitroVmaxPerRecombinantEnzyme,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole-CYP3A4-Isoherranen 2004|In vitro Vmax/recombinant enzyme,0.0869,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole-CYP3A4-Isoherranen 2004|Km,0.0022214874285,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Keto-Itraconazole-CYP3A4-Isoherranen 2004|kcat,0.3933927416,InVitroVmaxPerRecombinantEnzyme,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|In vitro Vmax/recombinant enzyme,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|Km,0.0006284266369,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|N-desalkyl-Itraconazole-CYP3A4-Isoherranen 2004|kcat,0.0605873508,InVitroVmaxPerRecombinantEnzyme,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Dissolution time (50% dissolved),26.95593161,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Lag time,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Dissolution shape,0.697109383,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Weibull parameter (alpha),0.0697433642290699,ln(2)/DissTime50^DissShape,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Use as suspension,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate of the tablet,0,Time >= StartTime+LagTime ? (beta*alpha*(Time+tplus-StartTime-LagTime)^(beta-1)*exp(-alpha*(Time+tplus-StartTime-LagTime)^beta)*DrugMass) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet time delay factor,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Cecum,0,Use_As_Suspension ? Suspension_Fraction_cae : Tablet_Location_cae,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Colon Ascendens,0,Use_As_Suspension ? Suspension_Fraction_colasc : Tablet_Location_colasc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Colon Descendens,0,Use_As_Suspension ? Suspension_Fraction_coldesc : Tablet_Location_coldesc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Colon Sigmoid,0,Use_As_Suspension ? Suspension_Fraction_colsigm : Tablet_Location_colsigm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Colon Transversum,0,Use_As_Suspension ? Suspension_Fraction_coltrans : Tablet_Location_coltrans,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Duodenum,0,Use_As_Suspension ? Suspension_Fraction_duo : Tablet_Location_duo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Lower Ileum,0,Use_As_Suspension ? Suspension_Fraction_lil : Tablet_Location_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Lower Jejunum,0,Use_As_Suspension ? Suspension_Fraction_lje : Tablet_Location_lje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Rectum,0,Use_As_Suspension ? Suspension_Fraction_rect : Tablet_Location_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Stomach,1,Use_As_Suspension ? Suspension_Fraction_sto : Tablet_Location_sto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Upper Ileum,0,Use_As_Suspension ? Suspension_Fraction_uil : Tablet_Location_uil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Release rate fraction Upper Jejunum,0,Use_As_Suspension ? Suspension_Fraction_uje : Tablet_Location_uje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Cecum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*w_lil*fraction_lil*FillLevelFlag_cae-w_cae*fraction_cae*FillLevelFlag_colasc) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Colon Ascendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_cae*fraction_cae*FillLevelFlag_colasc-w_colasc*fraction_colasc*FillLevelFlag_coltrans ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Colon Descendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coltrans*fraction_coltrans*FillLevelFlag_coldesc-w_coldesc*fraction_coldesc*FillLevelFlag_colsigm) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Colon Sigmoid,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coldesc*fraction_coldesc*FillLevelFlag_colsigm-w_colsigm*fraction_colsigm*FillLevelFlag_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Colon Transversum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colasc*fraction_colasc*FillLevelFlag_coltrans-w_coltrans*fraction_coltrans*FillLevelFlag_coldesc ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Duodenum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*fraction_sto*FillLevelFlag_duo-w_duo*fraction_duo*FillLevelFlag_uje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Lower Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uil*fraction_uil*FillLevelFlag_lil-w_lil*fraction_lil*FillLevelFlag_cae)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Lower Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uje*fraction_uje*FillLevelFlag_lje-w_lje*fraction_lje*FillLevelFlag_uil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Rectum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colsigm*fraction_colsigm*FillLevelFlag_rect-w_rect*fraction_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Stomach,0,Use_As_Suspension ? 1 : 0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (-w_fact*(w_sto*fraction_sto*FillLevelFlag_duo)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Upper Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_lje*fraction_lje*FillLevelFlag_uil-w_uil*fraction_uil*FillLevelFlag_lil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Suspension fraction Upper Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_duo*fraction_duo*FillLevelFlag_uje-w_uje*fraction_uje*FillLevelFlag_lje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location,1.99,Use_As_Suspension ? 0 : 1.99,Use_As_Suspension ? 0 : (TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*location_sto*FillLevelFlag_duo*(Time>StartTime+LagTime?1:0) +w_duo*location_duo*FillLevelFlag_uje +w_uje*location_uje*FillLevelFlag_lje +w_lje*location_lje*FillLevelFlag_uil +w_uil*location_uil*FillLevelFlag_lil +w_lil*location_lil*FillLevelFlag_cae) +w_cae*location_cae*FillLevelFlag_colasc +w_colasc*location_colasc*FillLevelFlag_coltrans +w_coltrans*location_coltrans*FillLevelFlag_coldesc +w_coldesc*location_coldesc*FillLevelFlag_colsigm +w_colsigm*location_colsigm*FillLevelFlag_rect +w_rect*location_rect) : 0)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_cae,0,location <8 & location >=7?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_colasc,0,location <9 & location >=8?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_coldesc,0,location <11 & location >=10?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_colsigm,0,location <12 & location >=11?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_coltrans,0,location <10 & location >=9?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_duo,0,location <3 & location >=2?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_lil,0,location <7 & location >=6?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_lje,0,location <5 & location >=4?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_rect,0,location <13 & location >=12?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_sto,1,location <2 & location >=1?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_uil,0,location <6 & location >=5?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_Location_uje,0,location <4 & location >=3?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Tablet_tplus,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|TabletIsActive,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|Start time,4440,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|Dose,7.5E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|DosePerBodySurfaceArea,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|DosePerBodyWeight,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|DrugMass,23.0223777511741,Dose / MW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|Amount of water,0.255500001555573,AmountOfWaterPerBodyWeight * BW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|ProtocolSchemaItem|Volume of water/body weight,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Midazolam|Tablet Midazolam (Roche)|Application_1|Midazolam|Concentration,23.0223777511741,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Dissolution time (50% dissolved),406.64,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Lag time,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Dissolution shape,1.1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Weibull parameter (alpha),0.000934747591220473,ln(2)/DissTime50^DissShape,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Use as suspension,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate of the tablet,0.0366022814946839,Time >= StartTime+LagTime ? (beta*alpha*(Time+tplus-StartTime-LagTime)^(beta-1)*exp(-alpha*(Time+tplus-StartTime-LagTime)^beta)*DrugMass) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet time delay factor,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Cecum,0,Use_As_Suspension ? Suspension_Fraction_cae : Tablet_Location_cae,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Colon Ascendens,0,Use_As_Suspension ? Suspension_Fraction_colasc : Tablet_Location_colasc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Colon Descendens,0,Use_As_Suspension ? Suspension_Fraction_coldesc : Tablet_Location_coldesc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Colon Sigmoid,0,Use_As_Suspension ? Suspension_Fraction_colsigm : Tablet_Location_colsigm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Colon Transversum,0,Use_As_Suspension ? Suspension_Fraction_coltrans : Tablet_Location_coltrans,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Duodenum,0,Use_As_Suspension ? Suspension_Fraction_duo : Tablet_Location_duo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Lower Ileum,0,Use_As_Suspension ? Suspension_Fraction_lil : Tablet_Location_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Lower Jejunum,0,Use_As_Suspension ? Suspension_Fraction_lje : Tablet_Location_lje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Rectum,0,Use_As_Suspension ? Suspension_Fraction_rect : Tablet_Location_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Stomach,1,Use_As_Suspension ? Suspension_Fraction_sto : Tablet_Location_sto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Upper Ileum,0,Use_As_Suspension ? Suspension_Fraction_uil : Tablet_Location_uil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Release rate fraction Upper Jejunum,0,Use_As_Suspension ? Suspension_Fraction_uje : Tablet_Location_uje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Cecum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*w_lil*fraction_lil*FillLevelFlag_cae-w_cae*fraction_cae*FillLevelFlag_colasc) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Colon Ascendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_cae*fraction_cae*FillLevelFlag_colasc-w_colasc*fraction_colasc*FillLevelFlag_coltrans ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Colon Descendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coltrans*fraction_coltrans*FillLevelFlag_coldesc-w_coldesc*fraction_coldesc*FillLevelFlag_colsigm) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Colon Sigmoid,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coldesc*fraction_coldesc*FillLevelFlag_colsigm-w_colsigm*fraction_colsigm*FillLevelFlag_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Colon Transversum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colasc*fraction_colasc*FillLevelFlag_coltrans-w_coltrans*fraction_coltrans*FillLevelFlag_coldesc ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Duodenum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*fraction_sto*FillLevelFlag_duo-w_duo*fraction_duo*FillLevelFlag_uje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Lower Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uil*fraction_uil*FillLevelFlag_lil-w_lil*fraction_lil*FillLevelFlag_cae)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Lower Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uje*fraction_uje*FillLevelFlag_lje-w_lje*fraction_lje*FillLevelFlag_uil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Rectum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colsigm*fraction_colsigm*FillLevelFlag_rect-w_rect*fraction_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Stomach,1,Use_As_Suspension ? 1 : 0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (-w_fact*(w_sto*fraction_sto*FillLevelFlag_duo)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Upper Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_lje*fraction_lje*FillLevelFlag_uil-w_uil*fraction_uil*FillLevelFlag_lil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Suspension fraction Upper Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_duo*fraction_duo*FillLevelFlag_uje-w_uje*fraction_uje*FillLevelFlag_lje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location,0,Use_As_Suspension ? 0 : 1.99,Use_As_Suspension ? 0 : (TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*location_sto*FillLevelFlag_duo*(Time>StartTime+LagTime?1:0) +w_duo*location_duo*FillLevelFlag_uje +w_uje*location_uje*FillLevelFlag_lje +w_lje*location_lje*FillLevelFlag_uil +w_uil*location_uil*FillLevelFlag_lil +w_lil*location_lil*FillLevelFlag_cae) +w_cae*location_cae*FillLevelFlag_colasc +w_colasc*location_colasc*FillLevelFlag_coltrans +w_coltrans*location_coltrans*FillLevelFlag_coldesc +w_coldesc*location_coldesc*FillLevelFlag_colsigm +w_colsigm*location_colsigm*FillLevelFlag_rect +w_rect*location_rect) : 0)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_cae,0,location <8 & location >=7?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_colasc,0,location <9 & location >=8?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_coldesc,0,location <11 & location >=10?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_colsigm,0,location <12 & location >=11?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_coltrans,0,location <10 & location >=9?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_duo,0,location <3 & location >=2?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_lil,0,location <7 & location >=6?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_lje,0,location <5 & location >=4?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_rect,0,location <13 & location >=12?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_sto,0,location <2 & location >=1?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_uil,0,location <6 & location >=5?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_Location_uje,0,location <4 & location >=3?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Tablet_tplus,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|TabletIsActive,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|Start time,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|Dose,0.0001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|DosePerBodySurfaceArea,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|DosePerBodyWeight,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|DrugMass,141.716728100868,Dose / MW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|Amount of water,0.255500001555573,AmountOfWaterPerBodyWeight * BW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|ProtocolSchemaItem|Volume of water/body weight,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_1|Itraconazole|Concentration,141.716728100868,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate of the tablet,0,Time >= StartTime+LagTime ? (beta*alpha*(Time+tplus-StartTime-LagTime)^(beta-1)*exp(-alpha*(Time+tplus-StartTime-LagTime)^beta)*DrugMass) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet time delay factor,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Cecum,0,Use_As_Suspension ? Suspension_Fraction_cae : Tablet_Location_cae,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Colon Ascendens,0,Use_As_Suspension ? Suspension_Fraction_colasc : Tablet_Location_colasc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Colon Descendens,0,Use_As_Suspension ? Suspension_Fraction_coldesc : Tablet_Location_coldesc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Colon Sigmoid,0,Use_As_Suspension ? Suspension_Fraction_colsigm : Tablet_Location_colsigm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Colon Transversum,0,Use_As_Suspension ? Suspension_Fraction_coltrans : Tablet_Location_coltrans,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Duodenum,0,Use_As_Suspension ? Suspension_Fraction_duo : Tablet_Location_duo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Lower Ileum,0,Use_As_Suspension ? Suspension_Fraction_lil : Tablet_Location_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Lower Jejunum,0,Use_As_Suspension ? Suspension_Fraction_lje : Tablet_Location_lje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Rectum,0,Use_As_Suspension ? Suspension_Fraction_rect : Tablet_Location_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Stomach,1,Use_As_Suspension ? Suspension_Fraction_sto : Tablet_Location_sto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Upper Ileum,0,Use_As_Suspension ? Suspension_Fraction_uil : Tablet_Location_uil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Release rate fraction Upper Jejunum,0,Use_As_Suspension ? Suspension_Fraction_uje : Tablet_Location_uje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Cecum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*w_lil*fraction_lil*FillLevelFlag_cae-w_cae*fraction_cae*FillLevelFlag_colasc) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Colon Ascendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_cae*fraction_cae*FillLevelFlag_colasc-w_colasc*fraction_colasc*FillLevelFlag_coltrans ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Colon Descendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coltrans*fraction_coltrans*FillLevelFlag_coldesc-w_coldesc*fraction_coldesc*FillLevelFlag_colsigm) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Colon Sigmoid,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coldesc*fraction_coldesc*FillLevelFlag_colsigm-w_colsigm*fraction_colsigm*FillLevelFlag_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Colon Transversum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colasc*fraction_colasc*FillLevelFlag_coltrans-w_coltrans*fraction_coltrans*FillLevelFlag_coldesc ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Duodenum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*fraction_sto*FillLevelFlag_duo-w_duo*fraction_duo*FillLevelFlag_uje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Lower Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uil*fraction_uil*FillLevelFlag_lil-w_lil*fraction_lil*FillLevelFlag_cae)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Lower Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uje*fraction_uje*FillLevelFlag_lje-w_lje*fraction_lje*FillLevelFlag_uil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Rectum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colsigm*fraction_colsigm*FillLevelFlag_rect-w_rect*fraction_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Stomach,1,Use_As_Suspension ? 1 : 0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (-w_fact*(w_sto*fraction_sto*FillLevelFlag_duo)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Upper Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_lje*fraction_lje*FillLevelFlag_uil-w_uil*fraction_uil*FillLevelFlag_lil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Suspension fraction Upper Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_duo*fraction_duo*FillLevelFlag_uje-w_uje*fraction_uje*FillLevelFlag_lje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location,0,Use_As_Suspension ? 0 : 1.99,Use_As_Suspension ? 0 : (TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*location_sto*FillLevelFlag_duo*(Time>StartTime+LagTime?1:0) +w_duo*location_duo*FillLevelFlag_uje +w_uje*location_uje*FillLevelFlag_lje +w_lje*location_lje*FillLevelFlag_uil +w_uil*location_uil*FillLevelFlag_lil +w_lil*location_lil*FillLevelFlag_cae) +w_cae*location_cae*FillLevelFlag_colasc +w_colasc*location_colasc*FillLevelFlag_coltrans +w_coltrans*location_coltrans*FillLevelFlag_coldesc +w_coldesc*location_coldesc*FillLevelFlag_colsigm +w_colsigm*location_colsigm*FillLevelFlag_rect +w_rect*location_rect) : 0)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_cae,0,location <8 & location >=7?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_colasc,0,location <9 & location >=8?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_coldesc,0,location <11 & location >=10?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_colsigm,0,location <12 & location >=11?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_coltrans,0,location <10 & location >=9?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_duo,0,location <3 & location >=2?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_lil,0,location <7 & location >=6?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_lje,0,location <5 & location >=4?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_rect,0,location <13 & location >=12?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_sto,0,location <2 & location >=1?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_uil,0,location <6 & location >=5?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_Location_uje,0,location <4 & location >=3?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Tablet_tplus,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|TabletIsActive,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|Start time,1440,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|Dose,0.0001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|DosePerBodySurfaceArea,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|DosePerBodyWeight,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|DrugMass,141.716728100868,Dose / MW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|Amount of water,0.255500001555573,AmountOfWaterPerBodyWeight * BW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|ProtocolSchemaItem|Volume of water/body weight,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_2|Itraconazole|Concentration,141.716728100868,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate of the tablet,0,Time >= StartTime+LagTime ? (beta*alpha*(Time+tplus-StartTime-LagTime)^(beta-1)*exp(-alpha*(Time+tplus-StartTime-LagTime)^beta)*DrugMass) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet time delay factor,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Cecum,0,Use_As_Suspension ? Suspension_Fraction_cae : Tablet_Location_cae,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Colon Ascendens,0,Use_As_Suspension ? Suspension_Fraction_colasc : Tablet_Location_colasc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Colon Descendens,0,Use_As_Suspension ? Suspension_Fraction_coldesc : Tablet_Location_coldesc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Colon Sigmoid,0,Use_As_Suspension ? Suspension_Fraction_colsigm : Tablet_Location_colsigm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Colon Transversum,0,Use_As_Suspension ? Suspension_Fraction_coltrans : Tablet_Location_coltrans,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Duodenum,0,Use_As_Suspension ? Suspension_Fraction_duo : Tablet_Location_duo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Lower Ileum,0,Use_As_Suspension ? Suspension_Fraction_lil : Tablet_Location_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Lower Jejunum,0,Use_As_Suspension ? Suspension_Fraction_lje : Tablet_Location_lje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Rectum,0,Use_As_Suspension ? Suspension_Fraction_rect : Tablet_Location_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Stomach,1,Use_As_Suspension ? Suspension_Fraction_sto : Tablet_Location_sto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Upper Ileum,0,Use_As_Suspension ? Suspension_Fraction_uil : Tablet_Location_uil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Release rate fraction Upper Jejunum,0,Use_As_Suspension ? Suspension_Fraction_uje : Tablet_Location_uje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Cecum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*w_lil*fraction_lil*FillLevelFlag_cae-w_cae*fraction_cae*FillLevelFlag_colasc) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Colon Ascendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_cae*fraction_cae*FillLevelFlag_colasc-w_colasc*fraction_colasc*FillLevelFlag_coltrans ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Colon Descendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coltrans*fraction_coltrans*FillLevelFlag_coldesc-w_coldesc*fraction_coldesc*FillLevelFlag_colsigm) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Colon Sigmoid,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coldesc*fraction_coldesc*FillLevelFlag_colsigm-w_colsigm*fraction_colsigm*FillLevelFlag_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Colon Transversum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colasc*fraction_colasc*FillLevelFlag_coltrans-w_coltrans*fraction_coltrans*FillLevelFlag_coldesc ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Duodenum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*fraction_sto*FillLevelFlag_duo-w_duo*fraction_duo*FillLevelFlag_uje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Lower Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uil*fraction_uil*FillLevelFlag_lil-w_lil*fraction_lil*FillLevelFlag_cae)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Lower Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uje*fraction_uje*FillLevelFlag_lje-w_lje*fraction_lje*FillLevelFlag_uil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Rectum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colsigm*fraction_colsigm*FillLevelFlag_rect-w_rect*fraction_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Stomach,1,Use_As_Suspension ? 1 : 0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (-w_fact*(w_sto*fraction_sto*FillLevelFlag_duo)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Upper Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_lje*fraction_lje*FillLevelFlag_uil-w_uil*fraction_uil*FillLevelFlag_lil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Suspension fraction Upper Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_duo*fraction_duo*FillLevelFlag_uje-w_uje*fraction_uje*FillLevelFlag_lje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location,0,Use_As_Suspension ? 0 : 1.99,Use_As_Suspension ? 0 : (TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*location_sto*FillLevelFlag_duo*(Time>StartTime+LagTime?1:0) +w_duo*location_duo*FillLevelFlag_uje +w_uje*location_uje*FillLevelFlag_lje +w_lje*location_lje*FillLevelFlag_uil +w_uil*location_uil*FillLevelFlag_lil +w_lil*location_lil*FillLevelFlag_cae) +w_cae*location_cae*FillLevelFlag_colasc +w_colasc*location_colasc*FillLevelFlag_coltrans +w_coltrans*location_coltrans*FillLevelFlag_coldesc +w_coldesc*location_coldesc*FillLevelFlag_colsigm +w_colsigm*location_colsigm*FillLevelFlag_rect +w_rect*location_rect) : 0)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_cae,0,location <8 & location >=7?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_colasc,0,location <9 & location >=8?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_coldesc,0,location <11 & location >=10?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_colsigm,0,location <12 & location >=11?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_coltrans,0,location <10 & location >=9?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_duo,0,location <3 & location >=2?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_lil,0,location <7 & location >=6?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_lje,0,location <5 & location >=4?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_rect,0,location <13 & location >=12?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_sto,0,location <2 & location >=1?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_uil,0,location <6 & location >=5?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_Location_uje,0,location <4 & location >=3?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Tablet_tplus,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|TabletIsActive,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|Start time,2880,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|Dose,0.0001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|DosePerBodySurfaceArea,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|DosePerBodyWeight,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|DrugMass,141.716728100868,Dose / MW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|Amount of water,0.255500001555573,AmountOfWaterPerBodyWeight * BW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|ProtocolSchemaItem|Volume of water/body weight,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_3|Itraconazole|Concentration,141.716728100868,V>0 ? M/V : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate of the tablet,0,Time >= StartTime+LagTime ? (beta*alpha*(Time+tplus-StartTime-LagTime)^(beta-1)*exp(-alpha*(Time+tplus-StartTime-LagTime)^beta)*DrugMass) : 0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet time delay factor,0.2,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Cecum,0,Use_As_Suspension ? Suspension_Fraction_cae : Tablet_Location_cae,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Colon Ascendens,0,Use_As_Suspension ? Suspension_Fraction_colasc : Tablet_Location_colasc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Colon Descendens,0,Use_As_Suspension ? Suspension_Fraction_coldesc : Tablet_Location_coldesc,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Colon Sigmoid,0,Use_As_Suspension ? Suspension_Fraction_colsigm : Tablet_Location_colsigm,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Colon Transversum,0,Use_As_Suspension ? Suspension_Fraction_coltrans : Tablet_Location_coltrans,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Duodenum,0,Use_As_Suspension ? Suspension_Fraction_duo : Tablet_Location_duo,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Lower Ileum,0,Use_As_Suspension ? Suspension_Fraction_lil : Tablet_Location_lil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Lower Jejunum,0,Use_As_Suspension ? Suspension_Fraction_lje : Tablet_Location_lje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Rectum,0,Use_As_Suspension ? Suspension_Fraction_rect : Tablet_Location_rect,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Stomach,1,Use_As_Suspension ? Suspension_Fraction_sto : Tablet_Location_sto,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Upper Ileum,0,Use_As_Suspension ? Suspension_Fraction_uil : Tablet_Location_uil,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Release rate fraction Upper Jejunum,0,Use_As_Suspension ? Suspension_Fraction_uje : Tablet_Location_uje,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Cecum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*w_lil*fraction_lil*FillLevelFlag_cae-w_cae*fraction_cae*FillLevelFlag_colasc) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Colon Ascendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_cae*fraction_cae*FillLevelFlag_colasc-w_colasc*fraction_colasc*FillLevelFlag_coltrans ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Colon Descendens,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coltrans*fraction_coltrans*FillLevelFlag_coldesc-w_coldesc*fraction_coldesc*FillLevelFlag_colsigm) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Colon Sigmoid,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_coldesc*fraction_coldesc*FillLevelFlag_colsigm-w_colsigm*fraction_colsigm*FillLevelFlag_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Colon Transversum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colasc*fraction_colasc*FillLevelFlag_coltrans-w_coltrans*fraction_coltrans*FillLevelFlag_coldesc ) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Duodenum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*fraction_sto*FillLevelFlag_duo-w_duo*fraction_duo*FillLevelFlag_uje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Lower Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uil*fraction_uil*FillLevelFlag_lil-w_lil*fraction_lil*FillLevelFlag_cae)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Lower Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_uje*fraction_uje*FillLevelFlag_lje-w_lje*fraction_lje*FillLevelFlag_uil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Rectum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_colsigm*fraction_colsigm*FillLevelFlag_rect-w_rect*fraction_rect) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Stomach,1,Use_As_Suspension ? 1 : 0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (-w_fact*(w_sto*fraction_sto*FillLevelFlag_duo)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Upper Ileum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_lje*fraction_lje*FillLevelFlag_uil-w_uil*fraction_uil*FillLevelFlag_lil)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Suspension fraction Upper Jejunum,0,0,Use_As_Suspension ? ( TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_duo*fraction_duo*FillLevelFlag_uje-w_uje*fraction_uje*FillLevelFlag_lje)) : 0)  : 0
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location,0,Use_As_Suspension ? 0 : 1.99,Use_As_Suspension ? 0 : (TabletIsActive AND OralApplicationsEnabled ? (w_fact*(w_sto*location_sto*FillLevelFlag_duo*(Time>StartTime+LagTime?1:0) +w_duo*location_duo*FillLevelFlag_uje +w_uje*location_uje*FillLevelFlag_lje +w_lje*location_lje*FillLevelFlag_uil +w_uil*location_uil*FillLevelFlag_lil +w_lil*location_lil*FillLevelFlag_cae) +w_cae*location_cae*FillLevelFlag_colasc +w_colasc*location_colasc*FillLevelFlag_coltrans +w_coltrans*location_coltrans*FillLevelFlag_coldesc +w_coldesc*location_coldesc*FillLevelFlag_colsigm +w_colsigm*location_colsigm*FillLevelFlag_rect +w_rect*location_rect) : 0)
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_cae,0,location <8 & location >=7?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_colasc,0,location <9 & location >=8?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_coldesc,0,location <11 & location >=10?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_colsigm,0,location <12 & location >=11?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_coltrans,0,location <10 & location >=9?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_duo,0,location <3 & location >=2?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_lil,0,location <7 & location >=6?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_lje,0,location <5 & location >=4?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_rect,0,location <13 & location >=12?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_sto,0,location <2 & location >=1?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_uil,0,location <6 & location >=5?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_Location_uje,0,location <4 & location >=3?1:0,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Tablet_tplus,1E-06,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|TabletIsActive,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Volume,1,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|Start time,4320,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|Dose,0.0001,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|DosePerBodySurfaceArea,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|DosePerBodyWeight,0,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|DrugMass,141.716728100868,Dose / MW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|Amount of water,0.255500001555573,AmountOfWaterPerBodyWeight * BW,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|ProtocolSchemaItem|Volume of water/body weight,0.0035,,
DDI Treatment Ahonen 1995 Midazolam + Itra 100mg MD|Applications|Ahonen 1995 Itraconazole 100 mg MD|Capsule fasted|Application_4|Itraconazole|Concentration,141.716728100868,V>0 ? M/V : 0,
